Epstein-Barr	O
virus	O
EBNA3C	B-protein
represses	O
Cp	B-DNA
,	O
the	O
major	O
promoter	O
for	O
EBNA	B-protein
expression	O
,	O
but	O
has	O
no	O
effect	O
on	O
the	O
promoter	O
of	O
the	O
cell	B-DNA
gene	I-DNA
CD21	I-DNA
.	O

EBNA3C	B-protein
is	O
a	O
potent	O
repressor	O
of	O
transcription	O
when	O
bound	O
to	O
DNA	O
as	O
a	O
fusion	O
with	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
(	O
DBD	B-protein
)	O
of	O
GALA	O
.	O

A	O
survey	O
of	O
promoters	O
has	O
revealed	O
that	O
the	O
wild-type	B-protein
,	I-protein
unfused	I-protein
EBNA3C	I-protein
can	O
specifically	O
repress	O
expression	O
from	O
reporter	B-DNA
plasmids	I-DNA
containing	O
the	O
Epstein-Barr	O
virus	O
Cp	B-DNA
latency-associated	I-DNA
promoter	I-DNA
.	O

Repression	O
of	O
Cp	B-DNA
activity	O
required	O
amino	B-protein
acids	I-protein
207	I-protein
to	I-protein
368	I-protein
,	O
which	O
encompasses	O
a	O
region	O
resembling	O
a	O
basic	B-protein
DBD	I-protein
adjacent	O
to	O
a	O
leucine	B-protein
zipper	I-protein
DNA	I-protein
binding	I-protein
motif	I-protein
and	O
a	O
site	O
which	O
binds	O
to	O
the	O
cellular	B-protein
factor	I-protein
CBF1/RBP-Jkappa	I-protein
.	O

However	O
,	O
amino	O
acids	O
207	O
to	O
368	O
are	O
dispensable	O
when	O
the	O
protein	O
is	O
bound	O
to	O
DNA	O
as	O
a	O
fusion	O
with	O
the	O
GAL4	O
DBD	B-protein
,	O
thus	O
implicating	O
this	O
region	O
in	O
DNA	O
binding	O
.	O

Mutation	O
of	O
the	O
CBF1/RBP-Jkappa	B-protein
binding	I-protein
site	I-protein
in	O
EBNA3C	B-protein
abrogated	O
repression	O
,	O
strongly	O
suggesting	O
that	O
CBF1/RBP-Jkappa	B-protein
is	O
necessary	O
for	O
targeting	O
the	O
viral	O
protein	O
to	O
Cp	B-DNA
.	O

Consistent	O
with	O
this	O
result	O
,	O
mutation	O
of	O
the	O
EBNA2	B-DNA
response	I-DNA
element	I-DNA
(	O
a	O
CBF1/RBP-Jkappa	B-DNA
binding	I-DNA
site	I-DNA
)	O
in	O
Cp	B-DNA
also	O
prevented	O
significant	O
repression	O
.	O

In	O
addition	O
,	O
amino	B-protein
acids	I-protein
346	I-protein
to	I-protein
543	I-protein
,	O
which	O
were	O
previously	O
defined	O
as	O
important	O
for	O
the	O
repressor	O
activity	O
of	O
the	O
GAL4-EBNA3C	B-protein
fusion	I-protein
proteins	I-protein
,	O
also	O
appear	O
to	O
be	O
necessary	O
for	O
the	O
repression	O
of	O
Cp	B-DNA
.	O

Since	O
repression	O
by	O
these	O
fusions	O
was	O
not	O
observed	O
in	O
all	O
cell	O
types	O
,	O
it	O
seems	O
likely	O
that	O
EBNA3C	B-protein
either	O
depends	O
on	O
a	O
corepressor	B-protein
which	O
may	O
interact	O
with	O
amino	B-protein
acids	I-protein
346	I-protein
to	I-protein
543	I-protein
or	O
is	O
modified	O
in	O
a	O
cell-specific	O
manner	O
in	O
order	O
to	O
repress	O
.	O

These	O
data	O
are	O
consistent	O
with	O
EBNA3C	B-protein
contributing	O
to	O
the	O
regulation	O
of	O
EBNA	B-protein
expression	O
in	O
latently	B-cell_type
infected	I-cell_type
B	I-cell_type
cells	I-cell_type
through	O
CBF1/RBP-Jkappa	B-protein
and	O
another	O
factor	O
,	O
but	O
this	O
need	O
not	O
directly	O
involve	O
EBNA2	B-protein
.	O

Finally	O
,	O
although	O
it	O
has	O
been	O
reported	O
that	O
EBNA3C	B-protein
can	O
upregulate	O
CD21	B-protein
in	O
some	O
B	B-cell_type
cells	I-cell_type
,	O
we	O
were	O
unable	O
to	O
demonstrate	O
any	O
effect	O
of	O
EBNA3C	B-protein
on	O
reporter	B-DNA
plasmids	I-DNA
which	O
contain	O
the	O
CD21	B-DNA
promoter	I-DNA
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Nov.	NULL
1997	NULL
,	NULL
p.	NULL
8552-8562	NULL
0022-538X/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Epstein-Barr	NULL
Virus	NULL
EBNA3C	NULL
Represses	NULL
Cp	NULL
,	NULL
the	NULL
Major	NULL
Promoter	NULL
for	NULL
EBNA	NULL
Expression	NULL
,	NULL
but	NULL
Has	NULL
No	NULL
Effect	NULL
on	NULL
the	NULL
Promoter	NULL
of	NULL
the	NULL
Cell	NULL
Gene	NULL
CD21	NULL
STOYAN	NULL
A.	NULL
RADKOV	NULL
,	NULL
**	NULL
MARK	NULL
BAIN	NULL
,	NULL
**¢	NULL
PAUL	NULL
J.	NULL
FARRELL	NULL
,	NULL
MICHELLE	NULL
WEST	NULL
,	NULL
``	NULL
MARTIN	NULL
ROWE	NULL
,	NULL
``	NULL
*	NULL
AND	NULL
MARTIN	NULL
J.	NULL
ALLDAY**	NULL
Department	NULL
of	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
``	NULL
Imperial	NULL
College	NULL
School	NULL
of	NULL
Medicine	NULL
at	NULL
St	NULL
Mary	NULL
's	NULL
,	NULL
London	NULL
W2	NULL
1PG	NULL
,	NULL
and	NULL
CRC	NULL
Institute	NULL
for	NULL
Cancer	NULL
Studies	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
B15	NULL
2TJ	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Wales	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Heath	NULL
Park	NULL
,	NULL
Cardiff	NULL
CF4	NULL
4XX	NULL
,	NULL
*	NULL
United	NULL
Kingdom	NULL
Received	NULL
21	NULL
May	NULL
1997/Accepted	NULL
30	NULL
July	NULL
1997	NULL
EBNA3C	NULL
is	NULL
a	NULL
potent	NULL
repressor	NULL
of	NULL
transcription	NULL
when	NULL
bound	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
fusion	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
of	NULL
GALA	NULL
.	NULL

A	NULL
survey	NULL
of	NULL
promoters	NULL
has	NULL
revealed	NULL
that	NULL
the	NULL
wild-type	NULL
,	NULL
unfused	NULL
EBNA3C	NULL
can	NULL
specifically	NULL
repress	NULL
expression	NULL
from	NULL
reporter	NULL
plasmids	NULL
containing	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
Cp	NULL
latency-associated	NULL
promoter	NULL
.	NULL

Repression	NULL
of	NULL
Cp	NULL
activity	NULL
required	NULL
amino	NULL
acids	NULL
207	NULL
to	NULL
368	NULL
,	NULL
which	NULL
encompasses	NULL
a	NULL
region	NULL
resembling	NULL
a	NULL
basic	NULL
DBD	NULL
adjacent	NULL
to	NULL
a	NULL
leucine	NULL
zipper	NULL
DNA	NULL
binding	NULL
motif	NULL
and	NULL
a	NULL
site	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
cellular	NULL
factor	NULL
CBF1/RBP-Jx	NULL
.	NULL

However	NULL
,	NULL
amino	NULL
acids	NULL
207	NULL
to	NULL
368	NULL
are	NULL
dispensable	NULL
when	NULL
the	NULL
protein	NULL
is	NULL
bound	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
fusion	NULL
with	NULL
the	NULL
GAL4	NULL
DBD	NULL
,	NULL
thus	NULL
implicating	NULL
this	NULL
region	NULL
in	NULL
DNA	NULL
binding	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
CBFI/RBP-J	NULL
binding	NULL
site	NULL
in	NULL
EBNA3C	NULL
abrogated	NULL
repression	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
CBFI/RBP-J	NULL
is	NULL
necessary	NULL
for	NULL
targeting	NULL
the	NULL
viral	NULL
protein	NULL
to	NULL
Cp	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
result	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
EBNA2	NULL
response	NULL
element	NULL
(	NULL
a	NULL
-J	NULL
binding	NULL
site	NULL
)	NULL
in	NULL
Cp	NULL
also	NULL
prevented	NULL
significant	NULL
repression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
amino	NULL
acids	NULL
346	NULL
to	NULL
543	NULL
,	NULL
which	NULL
were	NULL
previously	NULL
defined	NULL
as	NULL
important	NULL
for	NULL
the	NULL
repressor	NULL
activity	NULL
of	NULL
the	NULL
GALA4-EBNA3C	NULL
fusion	NULL
proteins	NULL
,	NULL
also	NULL
appear	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
.	NULL

Since	NULL
repression	NULL
by	NULL
these	NULL
fusions	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
EBNA3C	NULL
either	NULL
depends	NULL
on	NULL
a	NULL
corepressor	NULL
which	NULL
may	NULL
interact	NULL
with	NULL
amino	NULL
acids	NULL
346	NULL
to	NULL
543	NULL
or	NULL
is	NULL
modified	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
in	NULL
order	NULL
to	NULL
repress	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
EBNA3C	NULL
contributing	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
EBNA	NULL
expression	NULL
in	NULL
latently	NULL
infected	NULL
B	NULL
cells	NULL
through	NULL
CBFI/RBP-Jx	NULL
and	NULL
another	NULL
factor	NULL
,	NULL
but	NULL
this	NULL
need	NULL
not	NULL
directly	NULL
involve	NULL
EBNAZ	NULL
.	NULL

Finally	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
EBNA3C	NULL
can	NULL
upregulate	NULL
CD21	NULL
in	NULL
some	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
any	NULL
effect	NULL
of	NULL
EBNA3C	NULL
on	NULL
reporter	NULL
plasmids	NULL
which	NULL
contain	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
can	NULL
induce	NULL
the	NULL
continuous	NULL
proliferation	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
resting	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
resulting	NULL
immortalized	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
have	NULL
a	NULL
phenotype	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
activated	NULL
B	NULL
lymphoblasts	NULL
and	NULL
express	NULL
nine	NULL
latent	NULL
viral	NULL
proteins	NULL
.	NULL

Together	NULL
these	NULL
proteins	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
which	NULL
then	NULL
enter	NULL
the	NULL
cell	NULL
division	NULL
cycle	NULL
,	NULL
induction	NULL
of	NULL
continuous	NULL
prolifer-ation	NULL
,	NULL
maintenance	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
in	NULL
its	NULL
latent	NULL
form	NULL
,	NULL
and	NULL
perhaps	NULL
prevention	NULL
of	NULL
terminal	NULL
differentiation	NULL
(	NULL
recently	NULL
reviewed	NULL
in	NULL
reference	NULL
18	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
EBV	NULL
is	NULL
the	NULL
causative	NULL
agent	NULL
in	NULL
the	NULL
benign	NULL
lymphoproliferation	NULL
known	NULL
as	NULL
infectious	NULL
mononucleosis	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
at	NULL
least	NULL
four	NULL
types	NULL
of	NULL
human	NULL
tumors	NULL
:	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
,	NULL
nasopharyngeal	NULL
carcinoma	NULL
,	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
and	NULL
lymphoma	NULL
in	NULL
immunocompromised	NULL
individuals	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
32	NULL
and	NULL
44	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
genes	NULL
expressed	NULL
in	NULL
LCL	NULL
s	NULL
include	NULL
six	NULL
genes	NULL
encoding	NULL
antigenic	NULL
proteins	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
:	NULL
EBNA1I	NULL
,	NULL
-2	NULL
,	NULL
-3A	NULL
,	NULL
-3B	NULL
,	NULL
-3C	NULL
,	NULL
and	NULL
-LP	NULL
(	NULL
the	NULL
last	NULL
four	NULL
are	NULL
also	NULL
known	NULL
as	NULL
EBNA3	NULL
,	NULL
-4	NULL
,	NULL
-6	NULL
,	NULL
and	NULL
-5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
there	NULL
are	NULL
three	NULL
latent	NULL
membrane	NULL
proteins	NULL
:	NULL
LMP1	NULL
,	NULL
LMP2A	NULL
,	NULL
and	NULL
LMP2B	NULL
(	NULL
also	NULL
known	NULL
as	NULL
LMP	NULL
,	NULL
TP1	NULL
,	NULL
and	NULL
TP2	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Three	NULL
of	NULL
the	NULL
nuclear	NULL
antigens	NULL
,	NULL
EBNA3A	NULL
,	NULL
-3B	NULL
,	NULL
and	NULL
-3C	NULL
,	NULL
are	NULL
considered	NULL
to	NULL
comprise	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Imperial	NULL
College	NULL
School	NULL
of	NULL
Medicine	NULL
at	NULL
St.	NULL
Mary	NULL
's	NULL
,	NULL
Norfolk	NULL
Place	NULL
,	NULL
London	NULL
W2	NULL
1PG	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
44	NULL
)	NULL
171	NULL
724	NULL
5522	NULL
,	NULL
ext	NULL
.	NULL

221	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
44	NULL
)	NULL
171	NULL
724	NULL
8586	NULL
.	NULL

E-mail	NULL
:	NULL
m.allday	NULL
@	NULL
ic.ac.uk	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Addenbrooke	NULL
's	NULL
Hospi-tal	NULL
,	NULL
Cambridge	NULL
CB2	NULL
200	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

8552	NULL
a	NULL
family	NULL
which	NULL
may	NULL
have	NULL
arisen	NULL
by	NULL
gene	NULL
duplication	NULL
since	NULL
they	NULL
share	NULL
limited	NULL
but	NULL
significant	NULL
amino	NULL
acid	NULL
homology	NULL
,	NULL
have	NULL
the	NULL
same	NULL
gene	NULL
structure	NULL
(	NULL
a	NULL
short	NULL
5	NULL
'	NULL
exon	NULL
and	NULL
a	NULL
long	NULL
3	NULL
'	NULL
exon	NULL
)	NULL
,	NULL
and	NULL
are	NULL
arranged	NULL
tandemly	NULL
in	NULL
the	NULL
EBV	NULL
genome	NULL
(	NULL
1	NULL
,	NULL
14	NULL
,	NULL
28	NULL
,	NULL
33	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Genetic	NULL
studies	NULL
using	NULL
recombinant	NULL
EBV	NULL
have	NULL
shown	NULL
that	NULL
EBNA3A	NULL
and	NULL
EBNA3C	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
immortalization	NULL
of	NULL
B	NULL
cells	NULL
whereas	NULL
EBNA3B	NULL
is	NULL
dispensable	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Experiments	NULL
in	NULL
which	NULL
EBNA3C	NULL
was	NULL
stably	NULL
expressed	NULL
after	NULL
transfection	NULL
into	NULL
EBV-negative	NULL
lymphoma	NULL
cells	NULL
produced	NULL
clones	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
CD21	NULL
antigen	NULL
(	NULL
50	NULL
)	NULL
.	NULL

In	NULL
similar	NULL
experiments	NULL
,	NULL
EBNA3C	NULL
was	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
in	NULL
EBV-positive	NULL
(	NULL
but	NULL
EBNA33C-negative	NULL
)	NULL
Raji	NULL
cells	NULL
arrested	NULL
early	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
division	NULL
cycle	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

EBNA3C	NULL
in	NULL
LCL	NULL
lysates	NULL
binds	NULL
to	NULL
DNA-cellulose	NULL
in	NULL
a	NULL
nonspecific	NULL
manner	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
experiments	NULL
using	NULL
recombinant	NULL
protein	NULL
produced	NULL
in	NULL
the	NULL
baculovirus	NULL
expression	NULL
system	NULL
suggest	NULL
that	NULL
it	NULL
may	NULL
bind	NULL
to	NULL
DNA	NULL
in	NULL
association	NULL
with	NULL
a	NULL
cellular	NULL
or	NULL
viral	NULL
protein	NULL
partner	NULL
(	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
nucleotide	NULL
sequence	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

EBNA3C	NULL
is	NULL
a	NULL
large	NULL
polypeptide	NULL
of	NULL
992	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
)	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
mass	NULL
of	NULL
~110	NULL
kDa	NULL
;	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gels	NULL
,	NULL
it	NULL
appears	NULL
even	NULL
larger	NULL
,	NULL
migrating	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
about	NULL
160	NULL
kDa	NULL
.	NULL

Analysis	NULL
of	NULL
its	NULL
predicted	NULL
sequence	NULL
has	NULL
revealed	NULL
features	NULL
common	NULL
to	NULL
many	NULL
viral	NULL
and	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
features	NULL
include	NULL
a	NULL
region	NULL
which	NULL
resembles	NULL
a	NULL
basic	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
adjacent	NULL
to	NULL
a	NULL
potential	NULL
leucine	NULL
zipper	NULL
motif	NULL
(	NULL
b-ZIP	NULL
)	NULL
and	NULL
regions	NULL
rich	NULL
in	NULL
acidic	NULL
,	NULL
proline	NULL
,	NULL
and	NULL
glutamine	NULL
residues	NULL
which	NULL
are	NULL
good	NULL
candidates	NULL
for	NULL
domains	NULL
involved	NULL
in	NULL
the	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
modulation	NULL
of	NULL
transcription	NULL
.	NULL

In	NULL
transient-transfection	NULL
assays	NULL
,	NULL
EBNA3C	NULL
can	NULL
modulate	NULL
the	NULL
EBNAZ-mediated	NULL
activation	NULL
of	NULL
the	NULL
LMP1	NULL
and	NULL
LMP2ZA	NULL
promoters	NULL
(	NULL
20	NULL
,	NULL
24	NULL
,	NULL
34	NULL
)	NULL
.	NULL

EBNAZ	NULL
activation	NULL
of	NULL
these	NULL
target	NULL
genes	NULL
is	NULL
complex	NULL
,	NULL
involving	NULL
interactions	NULL
with	NULL
various	NULL
cellular	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
factors	NULL
include	NULL
CBF1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
RBP-Jk	NULL
)	NULL
,	NULL
PU1	NULL
family	NULL
members	NULL
,	NULL
and	NULL
proteins	NULL
including	NULL
a	NULL
POU	NULL
domain	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
21	NULL
,	NULL
22	NULL
,	NULL
26	NULL
,	NULL
41	NULL
,	NULL
42	NULL
,	NULL
48	NULL
,	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

The	NULL
best	NULL
characterized	NULL
of	NULL
these	NULL
interactions	NULL
involves	NULL
the	NULL
binding	NULL
of	NULL
EBNAZ	NULL
to	NULL
CBF1/RBP-Jk	NULL
.	NULL

Binding	NULL
of	NULL
CBFI/RBP-Jx	NULL
to	NULL
the	NULL
DNA	NULL
sequence	NULL
5-GTGGGAA-3	NULL
'	NULL
in	NULL
the	NULL
EBV	NULL
latency-associated	NULL
promoter	NULL
,	NULL
Cp	NULL
,	NULL
targets	NULL
EBNAZ	NULL
to	NULL
DNA	NULL
,	NULL
which	NULL
directs	NULL
a	NULL
strong	NULL
activation	NULL
domain	NULL
in	NULL
EBNAZ	NULL
to	NULL
the	NULL
promoter	NULL
and	NULL
also	NULL
interferes	NULL
with	NULL
the	NULL
interaction	NULL
between	NULL
a	NULL
corepressor	NULL
that	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
CBFI/RBP-Jx	NULL
;	NULL
the	NULL
net	NULL
result	NULL
is	NULL
strong	NULL
activation	NULL
of	NULL
transcription	NULL
(	NULL
47	NULL
,	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

The	NULL
N-terminal	NULL
250	NULL
aa	NULL
of	NULL
EBNA3C	NULL
also	NULL
contain	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
CBF1/RBP-Jx	NULL
,	NULL
which	NULL
is	NULL
located	NULL
around	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
(	NULL
35	NULL
,	NULL
53	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
physical	NULL
interaction	NULL
between	NULL
EBNA3C	NULL
and	NULL
CBFI/RBP-Jx	NULL
appears	NULL
to	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
latter	NULL
to	NULL
DNA	NULL
,	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
34	NULL
,	NULL
49	NULL
,	NULL
53	NULL
)	NULL
.	NULL

This	NULL
protein-protein	NULL
interaction	NULL
,	NULL
which	NULL
prevents	NULL
the	NULL
association	NULL
of	NULL
the	NULL
EBNAZ-CBFI/RBP-Jxk	NULL
complex	NULL
with	NULL
DNA	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
EBNA3C-mediated	NULL
repression	NULL
of	NULL
EBNAZ	NULL
activation	NULL
shown	NULL
on	NULL
various	NULL
natural	NULL
and	NULL
synthetic	NULL
promoters	NULL
which	NULL
include	NULL
CBF1/RBP-Jx	NULL
binding	NULL
sites	NULL
.	NULL

CBFI/RBP-Jx	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
which	NULL
includes	NULL
the	NULL
Suppressor	NULL
of	NULL
Hairless	NULL
[	NULL
Su	NULL
(	NULL
H	NULL
)	NULL
]	NULL
in	NULL
Drosophila	NULL
melanogaster	NULL
.	NULL

In	NULL
both	NULL
Drosophila	NULL
and	NULL
mammalian	NULL
cells	NULL
,	NULL
these	NULL
proteins	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
signalling	NULL
from	NULL
the	NULL
Notch	NULL
family	NULL
of	NULL
membrane	NULL
receptors	NULL
.	NULL

A	NULL
truncated	NULL
form	NULL
of	NULL
murine	NULL
Notch	NULL
,	NULL
consisting	NULL
only	NULL
of	NULL
the	NULL
intracellular	NULL
domain	NULL
(	NULL
Notch	NULL
IC	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
function	NULL
as	NULL
an	NULL
activated	NULL
receptor	NULL
.	NULL

EBNAZ	NULL
is	NULL
thought	NULL
to	NULL
function	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
to	NULL
the	NULL
human	NULL
Notch	NULL
IC	NULL
,	NULL
and	NULL
since	NULL
in	NULL
Drosoph-ila	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
Hairless	NULL
gene	NULL
regulates	NULL
the	NULL
function	NULL
of	NULL
Su	NULL
(	NULL
H	NULL
)	NULL
by	NULL
inhibiting	NULL
its	NULL
binding	NULL
to	NULL
DNA	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
EBNA3C	NULL
mimics	NULL
the	NULL
mammalian	NULL
equivalent	NULL
of	NULL
Hairless	NULL
(	NULL
13	NULL
,	NULL
35	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Another	NULL
recent	NULL
study	NULL
in	NULL
which	NULL
a	NULL
fragment	NULL
of	NULL
EBNA3C	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
DBD	NULL
of	NULL
the	NULL
Saccharomyces	NULL
cerevisiae	NULL
transactivator	NULL
GAL4	NULL
showed	NULL
that	NULL
aa	NULL
724	NULL
to	NULL
826	NULL
can	NULL
activate	NULL
transcription	NULL
when	NULL
bound	NULL
to	NULL
DNA	NULL
(	NULL
24	NULL
)	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
studies	NULL
using	NULL
GALA	NULL
fusions	NULL
with	NULL
larger	NULL
EBNA3C	NULL
fragments	NULL
,	NULL
for	NULL
example	NULL
,	NULL
aa	NULL
11	NULL
to	NULL
992	NULL
and	NULL
580	NULL
to	NULL
992	NULL
,	NULL
showed	NULL
that	NULL
when	NULL
tethered	NULL
to	NULL
DNA	NULL
,	NULL
EBNA3C	NULL
can	NULL
be	NULL
a	NULL
very	NULL
potent	NULL
repressor	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
(	NULL
4	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
larger	NULL
fragments	NULL
and	NULL
the	NULL
near-full-length	NULL
protein	NULL
,	NULL
the	NULL
activation	NULL
domain	NULL
is	NULL
apparently	NULL
masked	NULL
.	NULL

Deletion	NULL
mapping	NULL
revealed	NULL
two	NULL
domains	NULL
which	NULL
contribute	NULL
to	NULL
the	NULL
repression	NULL
;	NULL
neither	NULL
region	NULL
of	NULL
the	NULL
protein	NULL
has	NULL
been	NULL
reported	NULL
as	NULL
necessary	NULL
for	NULL
the	NULL
physical	NULL
interaction	NULL
with	NULL
CBF1/	NULL
RBP-Jx	NULL
(	NULL
4	NULL
,	NULL
53	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
these	NULL
domains	NULL
suggests	NULL
that	NULL
EBNA3C	NULL
also	NULL
represses	NULL
transcription	NULL
by	NULL
an	NULL
additional	NULL
,	NULL
CBF1/RBP-Jk-independent	NULL
mechanism	NULL
which	NULL
may	NULL
involve	NULL
association	NULL
with	NULL
another	NULL
cellular	NULL
protein	NULL
(	NULL
or	NULL
proteins	NULL
)	NULL
.	NULL

We	NULL
recently	NULL
demonstrated	NULL
that	NULL
EBNA3C	NULL
is	NULL
an	NULL
immortalizing	NULL
protein	NULL
in	NULL
the	NULL
same	NULL
class	NULL
as	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
E7	NULL
and	NULL
adenovirus	NULL
E1A	NULL
(	NULL
27	NULL
)	NULL
.	NULL

That	NULL
is	NULL
,	NULL
it	NULL
can	NULL
cooperate	NULL
in	NULL
cotransfection	NULL
assays	NULL
with	NULL
activated	NULL
(	NULL
Ha-	NULL
)	NULL
as	NULL
to	NULL
immortalize	NULL
and	NULL
transform	NULL
primary	NULL
rodent	NULL
fibroblasts	NULL
,	NULL
and	NULL
it	NULL
can	NULL
also	NULL
activate	NULL
transcription	NULL
through	NULL
an	NULL
EZF	NULL
response	NULL
element	NULL
.	NULL

Since	NULL
EBNA3C	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
pRb	NULL
)	NULL
in	NULL
vitro	NULL
,	NULL
in	NULL
a	NULL
manner	NULL
which	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
pocket	NULL
region	NULL
of	NULL
pRb	NULL
,	NULL
we	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
EBNA33C-pRb	NULL
interaction	NULL
may	NULL
also	NULL
occur	NULL
in	NULL
vivo	NULL
and	NULL
contribute	NULL
toward	NULL
both	NULL
transformation-immortalization	NULL
and	NULL
the	NULL
repressor	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
27	NULL
)	NULL
.	NULL

EBV	NULL
EBNA3C	NULL
REPRESSES	NULL
Cp	NULL
BUT	NULL
NOT	NULL
THE	NULL
CD21	NULL
PROMOTER	NULL
-	NULL
8553	NULL
This	NULL
study	NULL
assessed	NULL
the	NULL
action	NULL
of	NULL
EBNA3C	NULL
on	NULL
the	NULL
EBV	NULL
latency-associated	NULL
promoter	NULL
Cp	NULL
,	NULL
the	NULL
promoter	NULL
for	NULL
its	NULL
own	NULL
RNA	NULL
in	NULL
most	NULL
LCLs	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
EBNA3C	NULL
on	NULL
the	NULL
CD21	NULL
promoter	NULL
was	NULL
also	NULL
determined	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
EBNA3C	NULL
can	NULL
repress	NULL
Cp	NULL
activity	NULL
whether	NULL
or	NULL
not	NULL
Cp	NULL
is	NULL
transactivated	NULL
by	NULL
EBNAZ	NULL
and	NULL
that	NULL
this	NULL
appears	NULL
to	NULL
require	NULL
CBF1/	NULL
RBP-Jx	NULL
to	NULL
target	NULL
EBNA3C	NULL
to	NULL
DNA	NULL
and	NULL
also	NULL
probably	NULL
depends	NULL
on	NULL
interaction	NULL
with	NULL
a	NULL
cofactor	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
latent	NULL
virus	NULL
infection	NULL
,	NULL
EBNA3C	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
negatively	NULL
regulate	NULL
its	NULL
own	NULL
expression	NULL
and	NULL
that	NULL
of	NULL
the	NULL
other	NULL
EBNAs	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
although	NULL
the	NULL
chromosomal	NULL
CD21	NULL
gene	NULL
is	NULL
apparently	NULL
upregulated	NULL
in	NULL
some	NULL
EBNA3C-expressing	NULL
cells	NULL
and	NULL
the	NULL
CD21	NULL
promoter	NULL
is	NULL
very	NULL
efficiently	NULL
transactivated	NULL
by	NULL
EBNAZ	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
any	NULL
effect	NULL
of	NULL
EBNA3C	NULL
on	NULL
its	NULL
activity	NULL
in	NULL
transient-transfection	NULL
assays	NULL
;	NULL
EBNA3C	NULL
did	NULL
not	NULL
activate	NULL
or	NULL
repress	NULL
CD21	NULL
reporter	NULL
plasmids	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

p-1425C-CAT	NULL
includes	NULL
the	NULL
B95-8	NULL
virus	NULL
C	NULL
promoter	NULL
region	NULL
(	NULL
nucleotides	NULL
9911	NULL
to	NULL
11336	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
fragment	NULL
of	NULL
pSVOCAT	NULL
and	NULL
cloned	NULL
into	NULL
pUC18	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
plasmid	NULL
includes	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Cp	NULL
region	NULL
(	NULL
TATA	NULL
box	NULL
at	NULL
position	NULL
11305	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

p-1425CE2RE-CAT	NULL
includes	NULL
nucleotides	NULL
9911	NULL
to	NULL
11336	NULL
with	NULL
a	NULL
five-nucleotide	NULL
mutation	NULL
of	NULL
the	NULL
EBNAZ	NULL
response	NULL
element	NULL
(	NULL
EZRE	NULL
)	NULL
(	NULL
RBP-J	NULL
«	NULL
/CBF1	NULL
binding	NULL
site	NULL
)	NULL
,	NULL
Le	NULL
.	NULL

,	NULL
5-GTGAATTC-3	NULL
'	NULL
in	NULL
place	NULL
of	NULL
5	NULL
``	NULL
-GTGGGAAA-3	NULL
'	NULL
,	NULL
subcloned	NULL
from	NULL
pGL-E2RE	NULL
(	NULL
7	NULL
)	NULL
.	NULL

pUAS-CAT	NULL
includes	NULL
five	NULL
copies	NULL
of	NULL
the	NULL
GALA4-binding	NULL
DNA	NULL
sequence	NULL
(	NULL
5'-CTCCGCTCGGAGGACAGTA-3	NULL
``	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
vector	NULL
pBLCAT2	NULL
(	NULL
51	NULL
)	NULL
.	NULL

These	NULL
sequences	NULL
are	NULL
located	NULL
approximately	NULL
120	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

p-1235CD21-CAT	NULL
includes	NULL
the	NULL
full-length	NULL
CD21	NULL
promoter	NULL
(	NULL
nucleotides	NULL
-1235	NULL
to	NULL
+75	NULL
)	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
pSP65CAT	NULL
vector	NULL
.	NULL

Plasmid	NULL
p-467CD21-CAT	NULL
includes	NULL
the	NULL
CD21	NULL
promoter	NULL
(	NULL
nucleotides	NULL
-467	NULL
to	NULL
+75	NULL
)	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
pSP65CAT	NULL
vector	NULL
(	NULL
31	NULL
)	NULL
.	NULL

pCMV-EBNA3C	NULL
includes	NULL
a	NULL
cDNA	NULL
encoding	NULL
EBNA3C	NULL
cloned	NULL
as	NULL
a	NULL
Smal/HindIII	NULL
fragment	NULL
from	NULL
pBSK-15	NULL
into	NULL
the	NULL
pBKCMV	NULL
vector	NULL
(	NULL
27	NULL
)	NULL
.	NULL

pJ144-C1	NULL
(	NULL
referred	NULL
to	NULL
hereafter	NULL
as	NULL
pSV-EBNA2	NULL
)	NULL
includes	NULL
the	NULL
Bg/II/NofI	NULL
fragment	NULL
of	NULL
the	NULL
BamHI	NULL
WYH	NULL
region	NULL
(	NULL
nucleotides	NULL
44664	NULL
to	NULL
50628	NULL
)	NULL
of	NULL
the	NULL
B95-8	NULL
strain	NULL
of	NULL
EBV	NULL
cloned	NULL
into	NULL
the	NULL
pSV2-gpt	NULL
vector	NULL
.	NULL

The	NULL
cloned	NULL
fragment	NULL
includes	NULL
the	NULL
Wp	NULL
region	NULL
and	NULL
the	NULL
entire	NULL
EBNAZ	NULL
gene	NULL
(	NULL
8	NULL
)	NULL
.	NULL

pSV-B-gal	NULL
includes	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

pBKCMV-EBNA3CA346-543	NULL
was	NULL
generated	NULL
by	NULL
transferring	NULL
the	NULL
EcoRV	NULL
fragment	NULL
from	NULL
pGal4-EBNA3Caal1-992A346-543	NULL
(	NULL
4	NULL
)	NULL
,	NULL
which	NULL
spans	NULL
the	NULL
deletion	NULL
,	NULL
into	NULL
pBKCMV-EBNA3C	NULL
.	NULL

The	NULL
pSGS5-EBNA3C	NULL
and	NULL
pSGS-EBNA3CA207-368	NULL
constructs	NULL
are	NULL
recombi-nants	NULL
based	NULL
on	NULL
the	NULL
pSGS	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
contain	NULL
a	NULL
wild-type	NULL
EBNA3C	NULL
cDNA	NULL
and	NULL
an	NULL
EBNA3CAbZIP	NULL
cDNA	NULL
with	NULL
codons	NULL
207	NULL
to	NULL
368	NULL
deleted	NULL
,	NULL
respec-tively	NULL
.	NULL

The	NULL
inserted	NULL
genes	NULL
are	NULL
placed	NULL
3	NULL
'	NULL
of	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
and	NULL
a	NULL
beta-globin	NULL
intron	NULL
.	NULL

The	NULL
EBNA3C	NULL
cDNA	NULL
was	NULL
derived	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
a	NULL
B95.8	NULL
cDNA	NULL
from	NULL
the	NULL
EBNA3C-pZip-neoSV	NULL
plasmid	NULL
(	NULL
28	NULL
)	NULL
with	NULL
primers	NULL
designed	NULL
to	NULL
insert	NULL
flanking	NULL
Smeal	NULL
sites	NULL
.	NULL

From	NULL
this	NULL
cDNA	NULL
,	NULL
the	NULL
AbZIP	NULL
cDNA	NULL
was	NULL
derived	NULL
by	NULL
removal	NULL
of	NULL
the	NULL
Hpal/Spel	NULL
restriction	NULL
fragment	NULL
,	NULL
followed	NULL
by	NULL
blunt-end	NULL
ligation	NULL
to	NULL
repair	NULL
the	NULL
gene	NULL
;	NULL
sequencing	NULL
revealed	NULL
that	NULL
the	NULL
nuclease	NULL
blunting	NULL
of	NULL
the	NULL
Spel	NULL
digest	NULL
caused	NULL
the	NULL
removal	NULL
of	NULL
an	NULL
additional	NULL
6	NULL
nucleotides	NULL
so	NULL
that	NULL
the	NULL
deletion	NULL
spanned	NULL
the	NULL
coordinates	NULL
99061	NULL
to	NULL
99548	NULL
,	NULL
leading	NULL
to	NULL
an	NULL
in-frame	NULL
deletion	NULL
removing	NULL
codons	NULL
207	NULL
to	NULL
368	NULL
.	NULL

The	NULL
Smal	NULL
restriction	NULL
fragments	NULL
containing	NULL
the	NULL
EBNA3C	NULL
cDNA	NULL
were	NULL
blunt	NULL
end	NULL
ligated	NULL
into	NULL
the	NULL
Bg/lI	NULL
site	NULL
of	NULL
the	NULL
pSGS	NULL
vector	NULL
.	NULL

pGALA4-EBNA3Caa11-992A207-368	NULL
was	NULL
constructed	NULL
by	NULL
transferring	NULL
the	NULL
EcoRV	NULL
fragment	NULL
from	NULL
pSGS5-EBNA3CA207-368	NULL
which	NULL
spans	NULL
the	NULL
deletion	NULL
,	NULL
into	NULL
pGALA-EBNA3Caa11-992	NULL
.	NULL

pSGS-EBNA3C-Jx	NULL
(	NULL
M	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
recombinant	NULL
PCR	NULL
,	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Two	NULL
overlapping	NULL
primers	NULL
,	NULL
5'-GGCTGCAGC	NULL
TGCGGCAGTTAACATGATGCT-3	NULL
'	NULL
and	NULL
5'-GCAGCTGCAGCCCAAAATG	NULL
CGGCACGAACT-3	NULL
'	NULL
,	NULL
were	NULL
used	NULL
to	NULL
replace	NULL
residues	NULL
Thr-209	NULL
(	NULL
T	NULL
)	NULL
,	NULL
Phe-210	NULL
(	NULL
F	NULL
)	NULL
,	NULL
Gly-211	NULL
(	NULL
G	NULL
)	NULL
,	NULL
and	NULL
Cys-212	NULL
(	NULL
C	NULL
)	NULL
with	NULL
alanine	NULL
(	NULL
A	NULL
)	NULL
residues	NULL
(	NULL
codons	NULL
in	NULL
bold	NULL
)	NULL
.	NULL

A	NULL
fragment	NULL
which	NULL
contained	NULL
the	NULL
mutated	NULL
region	NULL
was	NULL
amplified	NULL
with	NULL
primers	NULL
5'-GAGAGATTGGTACCAGAAGAGTCATACTCA-3	NULL
'	NULL
and	NULL
5'-TAGATTCT	NULL
TCGGTACCGCCTCTGC-3	NULL
'	NULL
which	NULL
include	NULL
KprI	NULL
restriction	NULL
endonuclease	NULL
sites	NULL
(	NULL
underlined	NULL
)	NULL
.	NULL

The	NULL
final	NULL
recombinant	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
KprI	NULL
,	NULL
and	NULL
the	NULL
purified	NULL
fragment	NULL
was	NULL
ligated	NULL
to	NULL
pSGS-EBNA3C	NULL
which	NULL
had	NULL
previously	NULL
been	NULL
digested	NULL
with	NULL
the	NULL
same	NULL
restriction	NULL
endonuclease	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
mutations	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
entire	NULL
fragment	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
protein	NULL
was	NULL
demonstrated	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
and	NULL
Western	NULL
blotting	NULL
of	NULL
extracts	NULL
from	NULL
transiently	NULL
transfected	NULL
DG75	NULL
cells	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

All	NULL
B	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
and	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
,	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
8554	NULL
RADKOV	NULL
ET	NULL
AL	NULL
.	NULL

Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
per	NULL
ml	NULL
(	NULL
all	NULL
Gibco	NULL
BRL	NULL
)	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
maintained	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
10	NULL
%	NULL
CO	NULL
;	NULL
atmosphere	NULL
.	NULL

Transient-transfection	NULL
assays	NULL
.	NULL

B	NULL
cells	NULL
were	NULL
split	NULL
1:3	NULL
with	NULL
fresh	NULL
growth	NULL
medium	NULL
12	NULL
to	NULL
16	NULL
h	NULL
before	NULL
transfection	NULL
.	NULL

Approximately	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
used	NULL
per	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
,	NULL
and	NULL
growth	NULL
medium	NULL
was	NULL
aspirated	NULL
and	NULL
retained	NULL
as	NULL
conditioned	NULL
medium	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
ice-cold	NULL
unsupplemented	NULL
RPMI	NULL
1640	NULL
(	NULL
150	NULL
pl	NULL
for	NULL
DG75	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
the	NULL
suspension	NULL
was	NULL
added	NULL
to	NULL
a	NULL
chilled	NULL
cuvette	NULL
(	NULL
0.4-cm	NULL
gap	NULL
;	NULL
Bio-Rad	NULL
)	NULL
which	NULL
contained	NULL
the	NULL
relevant	NULL
DNA	NULL
suspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
ice-cold	NULL
unsupplemented	NULL
RPMI	NULL
1640	NULL
.	NULL

The	NULL
cell	NULL
suspension	NULL
was	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
electroporated	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
set	NULL
at	NULL
a	NULL
capacitance	NULL
of	NULL
960	NULL
wF	NULL
and	NULL
250	NULL
V.	NULL
Transfected	NULL
cells	NULL
were	NULL
placed	NULL
at	NULL
37°C	NULL
for	NULL
20	NULL
min	NULL
before	NULL
being	NULL
resuspended	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
conditioned	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
extracts	NULL
were	NULL
prepared	NULL
40	NULL
to	NULL
48	NULL
h	NULL
posttransfection	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
method	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
6-cm-diameter	NULL
tissue	NULL
culture	NULL
dishes	NULL
the	NULL
evening	NULL
before	NULL
transfection	NULL
.	NULL

Thirty-two	NULL
microliters	NULL
of	NULL
2	NULL
M	NULL
CaCl	NULL
,	NULL
was	NULL
added	NULL
to	NULL
plasmid	NULL
mixes	NULL
,	NULL
and	NULL
each	NULL
mix	NULL
was	NULL
made	NULL
up	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
250	NULL
wl	NULL
with	NULL
double-distilled	NULL
water	NULL
.	NULL

This	NULL
solution	NULL
was	NULL
added	NULL
,	NULL
drop	NULL
by	NULL
drop	NULL
,	NULL
to	NULL
250	NULL
ul	NULL
of	NULL
2	NULL
%	NULL
HBS	NULL
(	NULL
10	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
to	NULL
30	NULL
min	NULL
until	NULL
a	NULL
very	NULL
fine	NULL
white	NULL
precipitate	NULL
formed	NULL
.	NULL

During	NULL
this	NULL
incubation	NULL
,	NULL
the	NULL
medium	NULL
in	NULL
each	NULL
dish	NULL
was	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
the	NULL
precipitate	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
relevant	NULL
dish	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
left	NULL
on	NULL
cells	NULL
overnight	NULL
and	NULL
then	NULL
removed	NULL
by	NULL
two	NULL
washes	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
refed	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
fresh	NULL
growth	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
lysates	NULL
were	NULL
prepared	NULL
24	NULL
h	NULL
later	NULL
.	NULL

In	NULL
all	NULL
transfections	NULL
,	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
input	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
including	NULL
the	NULL
appropriate	NULL
empty	NULL
vector	NULL
.	NULL

Every	NULL
experiment	NULL
was	NULL
performed	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
times	NULL
with	NULL
multiple	NULL
batches	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
pSV-B-gal	NULL
was	NULL
included	NULL
as	NULL
a	NULL
control	NULL
in	NULL
all	NULL
transfections	NULL
.	NULL

Transfected	NULL
B	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
(	NULL
1,100	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
1.5-ml	NULL
tubes	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
60	NULL
pl	NULL
of	NULL
cold	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
and	NULL
then	NULL
lysed	NULL
by	NULL
four	NULL
cycles	NULL
of	NULL
freeze-thaw	NULL
(	NULL
5	NULL
min	NULL
in	NULL
dry	NULL
ice-ethanol	NULL
and	NULL
5	NULL
min	NULL
in	NULL
a	NULL
37°C	NULL
water	NULL
bath	NULL
followed	NULL
by	NULL
a	NULL
10-s	NULL
vortex	NULL
)	NULL
.	NULL

Cell	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
(	NULL
14,000	NULL
rpm	NULL
in	NULL
an	NULL
Eppendorf	NULL
5402	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
fresh	NULL
tube	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
for	NULL
a	NULL
maximum	NULL
of	NULL
4	NULL
weeks	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
the	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
.	NULL

They	NULL
were	NULL
then	NULL
scraped	NULL
into	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
and	NULL
transferred	NULL
to	NULL
1.5-ml	NULL
tubes	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
(	NULL
6,500	NULL
rpm	NULL
in	NULL
an	NULL
Eppendorf	NULL
5402	NULL
for	NULL
30	NULL
s	NULL
at	NULL
4°C	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
60	NULL
pl	NULL
of	NULL
cold	NULL
0.25	NULL
M	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
B	NULL
cells	NULL
.	NULL

All	NULL
extracts	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
)	NULL
,	NULL
before	NULL
thin-layer	NULL
chromatography	NULL
(	NULL
TLC	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Liquid	NULL
scintillation	NULL
CAT	NULL
assays	NULL
with	NULL
[	NULL
'*CJacetyl	NULL
coenzyme	NULL
A	NULL
and	NULL
TLC	NULL
CAT	NULL
assays	NULL
with	NULL
[	NULL
**CJchloramphenicol	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
19	NULL
,	NULL
43	NULL
)	NULL
.	NULL

When	NULL
necessary	NULL
,	NULL
extracts	NULL
were	NULL
diluted	NULL
to	NULL
ensure	NULL
the	NULL
assay	NULL
was	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
(	NULL
approximately	NULL
20	NULL
to	NULL
40	NULL
%	NULL
conversion	NULL
for	NULL
the	NULL
TLC-based	NULL
assays	NULL
and	NULL
1,000	NULL
to	NULL
80,000	NULL
epm	NULL
for	NULL
the	NULL
liquid	NULL
scintillation-based	NULL
assays	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

Protein	NULL
gel	NULL
electrophoresis	NULL
and	NULL
Western	NULL
blotting	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
with	NULL
E3C.A10	NULL
,	NULL
a	NULL
monoclonal	NULL
antibody	NULL
which	NULL
recognizes	NULL
the	NULL
epitope	NULL
WAPSV	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
aa	NULL
682	NULL
to	NULL
686	NULL
of	NULL
the	NULL
B95-8	NULL
EBNA3C	NULL
protein	NULL
(	NULL
25	NULL
)	NULL
,	NULL
or	NULL
a	NULL
rabbit	NULL
anti-CBFI/RBP-J	NULL
«	NULL
serum	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Inmunofluorescence	NULL
microscopy	NULL
.	NULL

Forty-cight	NULL
hours	NULL
after	NULL
transfection	NULL
with	NULL
pBKCMVA346-543	NULL
in	NULL
3.5-cm-diameter	NULL
tissue	NULL
culture	NULL
dishes	NULL
,	NULL
C33A	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
fixed	NULL
with	NULL
acetone-methanol	NULL
(	NULL
1:1	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
-20°C	NULL
.	NULL

Cells	NULL
were	NULL
rehydrated	NULL
for	NULL
10	NULL
to	NULL
15	NULL
min	NULL
in	NULL
PBS	NULL
containing	NULL
20	NULL
%	NULL
normal	NULL
rabbit	NULL
serum	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
E3C.A10	NULL
(	NULL
neat	NULL
tissue	NULL
culture	NULL
supernatant	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
dishes	NULL
,	NULL
and	NULL
they	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

After	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
a	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
was	NULL
added	NULL
and	NULL
the	NULL
dishes	NULL
were	NULL
again	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
finally	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
Citifluor	NULL
was	NULL
applied	NULL
,	NULL
and	NULL
they	NULL
were	NULL
examined	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

GST	NULL
fusion	NULL
pull-down	NULL
assays	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
cach	NULL
in	NULL
vitro-translated	NULL
protein	NULL
was	NULL
incubated	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
EBC	NULL
buffer	NULL
(	NULL
140	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
200	NULL
M	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
)	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
and	NULL
5	NULL
pl	NULL
of	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-coated	NULL
Sepharose	NULL
beads	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
rotating	NULL
at	NULL
4°C	NULL
to	NULL
preclear	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
beads	NULL
coated	NULL
with	NULL
100	NULL
to	NULL
500	NULL
ng	NULL
of	NULL
GST	NULL
-Jx	NULL
fusion	NULL
protein	NULL
or	NULL
GST-coated	NULL
beads	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
NETN	NULL
buffer	NULL
(	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
)	NULL
,	NULL
with	NULL
vigorous	NULL
vortexing	NULL
during	NULL
each	NULL
wash	NULL
.	NULL

The	NULL
pellets	NULL
of	NULL
beads	NULL
were	NULL
boiled	NULL
in	NULL
80	NULL
wl	NULL
of	NULL
SDS	NULL
sample	NULL
buffer	NULL
to	NULL
solubilize	NULL
the	NULL
proteins	NULL
which	NULL
were	NULL
then	NULL
resolved	NULL
on	NULL
an	NULL
SDS-7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
coupled	NULL
transcription-translation	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
TNT	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
and	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
produced	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
quantified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
,	NULL
27	NULL
)	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

A	NULL
GRE	NULL
Jk	NULL
P-1425C-CAT	NULL
&	NULL
9911	NULL
11336	NULL
Jk	NULL
GRE	NULL
mutant	NULL
P-1425C-CAT	NULL
%	NULL
[	NULL
____cAT	NULL
_	NULL
___	NULL
]	NULL
E2RE	NULL
9911	NULL
11336	NULL
B	NULL
bZIP	NULL
Acidic	NULL
Proline/Glutamine	NULL
pCMVy	NULL
EBNA3C	NULL
___	NULL
(	NULL
0	NULL
|	NULL
[	NULL
t	NULL
Of	NULL
0	NULL
I	NULL
992	NULL
ceri	NULL
binding	NULL
40	NULL
pCMV	NULL
EBNA3C	NULL
36	NULL
fas	NULL
346-543	NULL
1	NULL
92	NULL
psas	NULL
EeNasc	NULL
C	NULL
--	NULL
-TBK	NULL
C	NULL
0	NULL
992	NULL
207	NULL
368	NULL
pSGS5	NULL
EBNA3C	NULL
£	NULL
207-368	NULL
gaz	NULL
0	NULL
208	NULL
AAAA	NULL
213	NULL
pSG5	NULL
EBNA3C	NULL
Jk	NULL
(	NULL
M	NULL
)	NULL
11	NULL
NAM	NULL
R	NULL
pGAL4	NULL
EBNA3C	NULL
aa11-992	NULL
GAL4	NULL
992	NULL
aa	NULL
1-147	NULL
11	NULL
207	NULL
368	NULL
pGAL4	NULL
EBNA3C	NULL
aa1	NULL
1-992	NULL
207-368	NULL
GAL4	NULL
pee	NULL
aa	NULL
1-147	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cp	NULL
reporter	NULL
constructs	NULL
.	NULL

p-1425C-CAT	NULL
includes	NULL
a	NULL
1.425-kbp	NULL
fragment	NULL
of	NULL
the	NULL
C	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

p-1425C-CAT-E2RE	NULL
encodes	NULL
the	NULL
Cp	NULL
fragment	NULL
,	NULL
containing	NULL
a	NULL
mutated	NULL
CBFI/RBP-Jx	NULL
site	NULL
(	NULL
5'-GTGGG	NULL
AAA-3	NULL
'	NULL
mutated	NULL
to	NULL
5'-GTGAATTC-3	NULL
'	NULL
)	NULL
,	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

This	NULL
mutated	NULL
site	NULL
no	NULL
longer	NULL
binds	NULL
CBFI/RBP-Jx	NULL
in	NULL
band	NULL
shift	NULL
assays	NULL
(	NULL
7	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
glucocorticoid	NULL
response	NULL
element	NULL
(	NULL
GRE	NULL
)	NULL
,	NULL
the	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
(	NULL
Jx	NULL
)	NULL
,	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
P	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
numbers	NULL
are	NULL
nucleotides	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Diagrammatic	NULL
representation	NULL
of	NULL
the	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
effector	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
for	NULL
details	NULL
of	NULL
all	NULL
constructions	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
.	NULL

pBKCMV	NULL
plasmids	NULL
are	NULL
labelled	NULL
pCMV	NULL
.	NULL

RESULTS	NULL
We	NULL
and	NULL
others	NULL
previously	NULL
showed	NULL
that	NULL
fusions	NULL
of	NULL
EBNA3C	NULL
(	NULL
aa	NULL
11	NULL
to	NULL
992	NULL
)	NULL
to	NULL
the	NULL
DBD	NULL
of	NULL
GAL4	NULL
could	NULL
repress	NULL
reporter	NULL
gene	NULL
expression	NULL
from	NULL
plasmids	NULL
including	NULL
GAL4	NULL
DNA-binding	NULL
sites	NULL
;	NULL
repression	NULL
was	NULL
absolutely	NULL
dependent	NULL
on	NULL
specific	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
wild-type	NULL
EBNA3C	NULL
could	NULL
have	NULL
a	NULL
similar	NULL
effect	NULL
on	NULL
any	NULL
naturally	NULL
occurring	NULL
promot-ers	NULL
,	NULL
we	NULL
surveyed	NULL
various	NULL
potential	NULL
targets	NULL
.	NULL

Since	NULL
it	NULL
is	NULL
quite	NULL
common	NULL
for	NULL
regulators	NULL
of	NULL
gene	NULL
expression	NULL
to	NULL
inhibit	NULL
their	NULL
own	NULL
transcription	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
human	NULL
cytomegalovirus	NULL
IE2	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
EBNA3C	NULL
on	NULL
the	NULL
EBNA	NULL
promoter	NULL
Cp	NULL
was	NULL
determined	NULL
.	NULL

voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
A	NULL
<	NULL
e	NULL
Gap	NULL
daa	NULL
»	NULL
wee	NULL
``	NULL
@	NULL
<	NULL
»	NULL
&	NULL
»	NULL
@	NULL
@	NULL
»	NULL
e	NULL
pBKCMV-E3C	NULL
5	NULL
3	NULL
p	NULL
§	NULL
16	NULL
so	NULL
ug	NULL
%	NULL
Acetylation	NULL
82	NULL
41	NULL
37.3	NULL
25.6	NULL
18.4	NULL
8.7	NULL
B	NULL
e	NULL
P	NULL
pSGSEsC	NULL
ug	NULL
0	NULL
1	NULL
2	NULL
5	NULL
10	NULL
20	NULL
%	NULL
Acetylation	NULL
57	NULL
27	NULL
17.3	NULL
13	NULL
8.7	NULL
5.2	NULL
pSG5EsC	NULL
o	NULL
A	NULL
3	NULL
5	NULL
19	NULL
ug	NULL
%	NULL
Acetylation	NULL
33	NULL
6.5	NULL
5	NULL
3.3	NULL
2.2	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

EBNA3C	NULL
can	NULL
repress	NULL
its	NULL
own	NULL
promoter	NULL
,	NULL
Cp	NULL
.	NULL

DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
g	NULL
of	NULL
p-1425C-CAT	NULL
which	NULL
includes	NULL
the	NULL
C	NULL
promoter	NULL
(	NULL
Cp	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

These	NULL
and	NULL
all	NULL
subsequent	NULL
transfections	NULL
also	NULL
included	NULL
2	NULL
pg	NULL
of	NULL
pSV-B-gal	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pBKCMV-EBNA3C	NULL
(	NULL
pBKCMV-E3C	NULL
)	NULL
(	NULL
A	NULL
)	NULL
or	NULL
pSGS-EBNA3C	NULL
(	NULL
pSGSE3C	NULL
)	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
,	NULL
after	NULL
normalization	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
analyzed	NULL
by	NULL
TLC	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
similar	NULL
series	NULL
of	NULL
transfections	NULL
performed	NULL
in	NULL
EBNAZ-positive	NULL
Raji	NULL
BL	NULL
cells	NULL
.	NULL

Expression	NULL
from	NULL
p-1425C-CAT	NULL
(	NULL
Cp	NULL
)	NULL
is	NULL
repressed	NULL
by	NULL
EBNA3C	NULL
.	NULL

In	NULL
an	NULL
initial	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
the	NULL
Cp	NULL
reporter	NULL
plasmid	NULL
p-1425C-CAT	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
EBNA3C	NULL
expression	NULL
vector	NULL
pBKCMV-EBNA3C	NULL
or	NULL
pSGS5-EBNA3C	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
into	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma-derived	NULL
cell	NULL
line	NULL
DG75	NULL
.	NULL

These	NULL
cells	NULL
sustain	NULL
a	NULL
reasonably	NULL
high	NULL
level	NULL
of	NULL
basal	NULL
activity	NULL
from	NULL
Cp	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EBNAZ	NULL
and	NULL
are	NULL
therefore	NULL
particularly	NULL
suitable	NULL
for	NULL
assaying	NULL
repression	NULL
.	NULL

However	NULL
,	NULL
the	NULL
promoter	NULL
can	NULL
still	NULL
be	NULL
activated	NULL
~10-fold	NULL
by	NULL
EBNAZ	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Multiple	NULL
titrations	NULL
showed	NULL
that	NULL
wild-type	NULL
EBNA3C	NULL
expression	NULL
represses	NULL
CAT	NULL
activity	NULL
driven	NULL
from	NULL
Cp	NULL
by	NULL
up	NULL
to	NULL
10-	NULL
to	NULL
20-fold	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
repression	NULL
to	NULL
Cp	NULL
was	NULL
ensured	NULL
by	NULL
including	NULL
pSV-B-gal	NULL
(	NULL
which	NULL
is	NULL
unaffected	NULL
by	NULL
EBNA3C	NULL
)	NULL
in	NULL
all	NULL
the	NULL
transfections	NULL
and	NULL
calculating	NULL
the	NULL
CAT	NULL
values	NULL
only	NULL
after	NULL
normalizing	NULL
to	NULL
the	NULL
B-galactosidase	NULL
EBV	NULL
EBNA3C	NULL
REPRESSES	NULL
Cp	NULL
BUT	NULL
NOT	NULL
THE	NULL
CD21	NULL
PROMOTER	NULL
-	NULL
8555	NULL
s	NULL
I	NULL
o	NULL
®	NULL
o	NULL
a.	NULL
s	NULL
I	NULL
kel	NULL
o	NULL
LL	NULL
T	NULL
``	NULL
lll	NULL
I	NULL
T	NULL
1	NULL
1	NULL
5	NULL
10	NULL
15	NULL
20	NULL
Nhl	NULL
ug	NULL
EFFECTOR	NULL
20	NULL
B	NULL
4	NULL
5	NULL
6	NULL
7	NULL
s	NULL
9	NULL
10	NULL
-l|	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Repression	NULL
of	NULL
Cp	NULL
requires	NULL
EBNA3C	NULL
aa	NULL
207	NULL
to	NULL
368	NULL
which	NULL
include	NULL
a	NULL
potential	NULL
b-ZIP	NULL
motif	NULL
and	NULL
a	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
pSGS-EBNA3CA207-368	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
p-1425C-CAT	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pSGS-EBNA3CA207-368	NULL
(	NULL
©	NULL
)	NULL
or	NULL
pSGS5-EBNA3C	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
plotted	NULL
values	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
for	NULL
three	NULL
experiments	NULL
analyzed	NULL
by	NULL
the	NULL
nonchromatographic	NULL
liquid	NULL
scintillation	NULL
method	NULL
after	NULL
normalization	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
(	NULL
43	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
results	NULL
of	NULL
Western	NULL
blot	NULL
analysis	NULL
show	NULL
that	NULL
the	NULL
mutant	NULL
and	NULL
wild-type	NULL
proteins	NULL
are	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
.	NULL

Lanes	NULL
1	NULL
to	NULL
5	NULL
,	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
pg	NULL
of	NULL
pSGS-EBNA3C	NULL
,	NULL
respectively	NULL
;	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
,	NULL
similar	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
pSGS5-A207-368	NULL
(	NULL
labelled	NULL
EBNA3CAbzip	NULL
)	NULL
.	NULL

B	NULL
1	NULL
EBNA3C	NULL
--	NULL
activity	NULL
.	NULL

The	NULL
level	NULL
of	NULL
input	NULL
DNA	NULL
in	NULL
this	NULL
and	NULL
all	NULL
subsequent	NULL
experiments	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
the	NULL
inclusion	NULL
of	NULL
control	NULL
plasmids	NULL
(	NULL
pBKCMV	NULL
or	NULL
pSG53	NULL
)	NULL
.	NULL

Raji	NULL
BL	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
all	NULL
the	NULL
EBNA	NULL
proteins	NULL
except	NULL
EBNA3C	NULL
(	NULL
1	NULL
)	NULL
,	NULL
were	NULL
also	NULL
transfected	NULL
in	NULL
similar	NULL
experiments	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
repression	NULL
of	NULL
Cp	NULL
occurred	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
endogenous	NULL
EBNAZ	NULL
encoded	NULL
by	NULL
the	NULL
Raji	NULL
virus	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
show	NULL
that	NULL
in	NULL
these	NULL
cells	NULL
EBNA3C	NULL
represses	NULL
Cp	NULL
as	NULL
efficiently	NULL
as	NULL
in	NULL
the	NULL
DG75	NULL
EBNAZ-negative	NULL
background	NULL
.	NULL

The	NULL
region	NULL
of	NULL
EBNA3C	NULL
which	NULL
includes	NULL
a	NULL
potential	NULL
b-ZIP	NULL
motif	NULL
and	NULL
a	NULL
CBFI/RBP-J	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
.	NULL

The	NULL
region	NULL
of	NULL
EBNA3C	NULL
between	NULL
aa	NULL
207	NULL
and	NULL
368	NULL
includes	NULL
two	NULL
motifs	NULL
which	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
targeting	NULL
EBNA3C	NULL
to	NULL
Cp	NULL
DNA	NULL
.	NULL

b-ZIP	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
introduction	NULL
)	NULL
are	NULL
frequently	NULL
associated	NULL
with	NULL
specific	NULL
DNA	NULL
binding	NULL
and	NULL
in	NULL
addition	NULL
the	NULL
residues	NULL
flanking	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
of	NULL
EBNA3C	NULL
bind	NULL
to	NULL
the	NULL
cellular	NULL
DNA-binding	NULL
factor	NULL
CBFI/RBP-Jk	NULL
(	NULL
53	NULL
)	NULL
.	NULL

A	NULL
deletion	NULL
mutant	NULL
from	NULL
which	NULL
aa	NULL
207	NULL
to	NULL
368	NULL
were	NULL
removed	NULL
(	NULL
pSGS-EBNA3CA207-368	NULL
[	NULL
Fig	NULL
.	NULL

1B	NULL
]	NULL
)	NULL
was	NULL
therefore	NULL
constructed	NULL
in	NULL
order	NULL
to	NULL
remove	NULL
these	NULL
features	NULL
from	NULL
EBNA3C	NULL
and	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
it	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
.	NULL

This	NULL
protein	NULL
failed	NULL
to	NULL
repress	NULL
Cp-driven	NULL
reporter	NULL
activity	NULL
signifi-cantly	NULL
,	NULL
whereas	NULL
wild-type	NULL
EBNA3C	NULL
,	NULL
expressed	NULL
from	NULL
a	NULL
similar	NULL
expression	NULL
vector	NULL
,	NULL
repressed	NULL
expression	NULL
from	NULL
Cp	NULL
by	NULL
10-	NULL
to	NULL
15-fold	NULL
.	NULL

Transfections	NULL
were	NULL
repeated	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
times	NULL
,	NULL
and	NULL
the	NULL
CAT	NULL
activity	NULL
was	NULL
assayed	NULL
by	NULL
the	NULL
liquid	NULL
scintillation	NULL
method	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
results	NULL
,	NULL
graphically	NULL
represented	NULL
as	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
showed	NULL
that	NULL
8556	NULL
RADKOV	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
20	NULL
Fold	NULL
repression	NULL
25	NULL
ug	NULL
EFFECTOR	NULL
B	NULL
tf	NULL
is	NULL
ic	NULL
2	NULL
tt	NULL
+2	NULL
_	NULL
all	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Site-specific	NULL
mutation	NULL
of	NULL
both	NULL
the	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
in	NULL
EBNA3C	NULL
and	NULL
the	NULL
E2RE	NULL
(	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
)	NULL
in	NULL
Cp	NULL
abrogates	NULL
repression	NULL
of	NULL
Cp	NULL
.	NULL

DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
amounts	NULL
of	NULL
pSGS-EBNA3C	NULL
or	NULL
pSGS-EBNA3C-Jk	NULL
(	NULL
M	NULL
)	NULL
indicated	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
p-1425C-CAT	NULL
or	NULL
p-1425C-CAT-E2RE	NULL
.	NULL

Extracts	NULL
were	NULL
analyzed	NULL
by	NULL
the	NULL
liquid	NULL
scintillation	NULL
method	NULL
in	NULL
order	NULL
to	NULL
directly	NULL
compare	NULL
the	NULL
activities	NULL
of	NULL
mutant	NULL
protein	NULL
and	NULL
mutant	NULL
promoter	NULL
with	NULL
wild-type	NULL
activities	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
of	NULL
three	NULL
titration	NULL
experiments	NULL
calculated	NULL
after	NULL
normalization	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
are	NULL
shown	NULL
.	NULL

Symbols	NULL
:	NULL
0	NULL
,	NULL
pSGS-EBNA3C	NULL
plus	NULL
wild-type	NULL
Cp	NULL
;	NULL
©	NULL
,	NULL
plus	NULL
wild-type	NULL
Cp	NULL
;	NULL
O	NULL
,	NULL
pSGS-EBNA3C	NULL
plus	NULL
p-1425C-CAT-EZRE	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
showing	NULL
expression	NULL
of	NULL
EBNA3C-Jk	NULL
(	NULL
M	NULL
)	NULL
.	NULL

Lanes	NULL
2	NULL
to	NULL
6	NULL
,	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
pSGS-EBNA3C	NULL
,	NULL
respectively	NULL
;	NULL
lanes	NULL
8	NULL
to	NULL
12	NULL
,	NULL
extracts	NULL
from	NULL
cells	NULL
similarly	NULL
transfected	NULL
with	NULL
pSGS-EBNA3C-Jk	NULL
(	NULL
M	NULL
)	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
,	NULL
extracts	NULL
from	NULL
untransfected	NULL
cells	NULL
.	NULL

ae	NULL
@	NULL
WD	NULL
-	NULL
EBnaco-uk	NULL
(	NULL
n	NULL
)	NULL
EBNASC	NULL
=-	NULL
this	NULL
deletion	NULL
mutant	NULL
is	NULL
unable	NULL
to	NULL
repress	NULL
Cp	NULL
activity	NULL
,	NULL
although	NULL
after	NULL
transfection	NULL
it	NULL
is	NULL
expressed	NULL
at	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
wild-type	NULL
EBNA3C	NULL
(	NULL
for	NULL
example	NULL
,	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Repression	NULL
of	NULL
Cp	NULL
requires	NULL
the	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
in	NULL
EBNA3C	NULL
and	NULL
the	NULL
E2RE	NULL
in	NULL
Cp	NULL
.	NULL

Zhao	NULL
and	NULL
colleagues	NULL
identified	NULL
a	NULL
short	NULL
sequence	NULL
of	NULL
amino	NULL
acids	NULL
surrounding	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
which	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
functional	NULL
interaction	NULL
between	NULL
EBNA3C	NULL
and	NULL
CBFI/RBP-Jk	NULL
(	NULL
53	NULL
)	NULL
.	NULL

This	NULL
site	NULL
is	NULL
located	NULL
near	NULL
the	NULL
potential	NULL
b-ZIP	NULL
and	NULL
was	NULL
also	NULL
deleted	NULL
in	NULL
A207-368	NULL
.	NULL

An	NULL
expression	NULL
vector	NULL
was	NULL
therefore	NULL
constructed	NULL
in	NULL
which	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
were	NULL
replaced	NULL
with	NULL
alanine	NULL
residues	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
previously	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
cotransfections	NULL
with	NULL
p-1425-CpCAT	NULL
demonstrated	NULL
a	NULL
requirement	NULL
for	NULL
these	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Both	NULL
mutant	NULL
and	NULL
wild-type	NULL
protein	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
after	NULL
transfection	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
site	NULL
in	NULL
EBNA3C	NULL
necessary	NULL
for	NULL
binding	NULL
to	NULL
CBF1/	NULL
RBP-Jx	NULL
is	NULL
required	NULL
for	NULL
repression	NULL
of	NULL
wild-type	NULL
Cp	NULL
,	NULL
the	NULL
reciprocal	NULL
experiment	NULL
with	NULL
a	NULL
mutant	NULL
promoter	NULL
and	NULL
wild-type	NULL
protein	NULL
was	NULL
performed	NULL
.	NULL

A	NULL
Cp	NULL
promoter	NULL
in	NULL
which	NULL
the	NULL
E2RE	NULL
or	NULL
RBP-Jk	NULL
binding	NULL
site	NULL
was	NULL
mutated	NULL
(	NULL
so	NULL
that	NULL
it	NULL
no	NULL
longer	NULL
binds	NULL
CBFI/RBP-Jx	NULL
)	NULL
was	NULL
subcloned	NULL
from	NULL
pGL-E2RE	NULL
(	NULL
7	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

The	NULL
results	NULL
of	NULL
cotransfecting	NULL
this	NULL
with	NULL
pSGS5-EBNA3C	NULL
are	NULL
also	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
.	NULL

The	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
CBF1I/RBP	NULL
-J	NULL
bound	NULL
to	NULL
its	NULL
cognate	NULL
site	NULL
in	NULL
Cp	NULL
targets	NULL
EBNA3C	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL

That	NULL
is	NULL
,	NULL
the	NULL
mutation	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
repression	NULL
by	NULL
EBNA3C	NULL
to	NULL
a	NULL
maximum	NULL
of	NULL
threefold	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
same	NULL
J.	NULL
Viror	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
1200	NULL
2400	NULL
100	NULL
300	NULL
-	NULL
600	NULL
ng	NULL
REPORTER	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
basal	NULL
activities	NULL
of	NULL
Cp	NULL
and	NULL
Cp	NULL
with	NULL
a	NULL
mutant	NULL
EZRE	NULL
are	NULL
very	NULL
similar	NULL
.	NULL

Parallel	NULL
transfections	NULL
of	NULL
DG75	NULL
cells	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
amounts	NULL
of	NULL
plasmid	NULL
DNA	NULL
indicated	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
liquid	NULL
scintillation	NULL
assay	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
for	NULL
three	NULL
separate	NULL
titration	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

p-1425C-CAT	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
and	NULL
p-1425C-CAT-EZRE	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

After	NULL
corrections	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
were	NULL
made	NULL
,	NULL
the	NULL
CAT	NULL
activity	NULL
from	NULL
100	NULL
ng	NULL
of	NULL
wild-type	NULL
promoter	NULL
plasmid	NULL
was	NULL
given	NULL
the	NULL
value	NULL
of	NULL
one	NULL
,	NULL
and	NULL
all	NULL
other	NULL
values	NULL
are	NULL
shown	NULL
relative	NULL
to	NULL
this	NULL
value	NULL
.	NULL

mutation	NULL
significantly	NULL
reduced	NULL
EBNAZ-mediated	NULL
transactivation	NULL
of	NULL
Cp	NULL
.	NULL

Cp	NULL
and	NULL
Cp	NULL
with	NULL
a	NULL
mutated	NULL
E2RE	NULL
have	NULL
similar	NULL
levels	NULL
of	NULL
basal	NULL
activity	NULL
.	NULL

An	NULL
alternative	NULL
interpretation	NULL
of	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
the	NULL
previous	NULL
two	NULL
sections	NULL
was	NULL
that	NULL
,	NULL
in	NULL
DG75	NULL
cells	NULL
,	NULL
Cp	NULL
activity	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
cellular	NULL
activation	NULL
pathway	NULL
(	NULL
for	NULL
in-stance	NULL
,	NULL
Notch	NULL
IC	NULL
[	NULL
see	NULL
introduction	NULL
]	NULL
)	NULL
acting	NULL
through	NULL
CBF1/	NULL
RBP-J	NULL
and	NULL
that	NULL
EBNA3C	NULL
,	NULL
by	NULL
interfering	NULL
with	NULL
CBF1/RBP-Jx	NULL
binding	NULL
to	NULL
DNA	NULL
apparently	NULL
induces	NULL
repression	NULL
.	NULL

In	NULL
order	NULL
to	NULL
establish	NULL
whether	NULL
EZRE	NULL
does	NULL
mediate	NULL
activation	NULL
through	NULL
CBF1/RBP-Jx	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
p-1425C-CAT	NULL
and	NULL
p-1425C-CAT-EZRE	NULL
reporters	NULL
were	NULL
transfected	NULL
,	NULL
in	NULL
parallel	NULL
,	NULL
into	NULL
DG75	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
multiple	NULL
experiments	NULL
using	NULL
various	NULL
batches	NULL
of	NULL
plasmid	NULL
failed	NULL
to	NULL
show	NULL
a	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
these	NULL
two	NULL
promoters	NULL
in	NULL
DG75	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
therefore	NULL
seems	NULL
very	NULL
unlikely	NULL
that	NULL
EBNA3C	NULL
represses	NULL
by	NULL
destabilizing	NULL
an	NULL
30	NULL
Fold	NULL
repression	NULL
0	NULL
U	NULL
U	NULL
I	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
ug	NULL
EFFECTOR	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

A	NULL
GAL4	NULL
DBD	NULL
can	NULL
functionally	NULL
substitute	NULL
for	NULL
aa	NULL
207	NULL
to	NULL
368	NULL
of	NULL
EBNA3C	NULL
.	NULL

DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pUAS-CAT	NULL
along	NULL
with	NULL
the	NULL
number	NULL
of	NULL
micrograms	NULL
of	NULL
pGAL4-E3CAbZip	NULL
(	NULL
pGAL4EBNA3Caa11-992A207-368	NULL
)	NULL
indicated	NULL
.	NULL

Multiple	NULL
transfections	NULL
of	NULL
DG75	NULL
with	NULL
pUAS-CAT	NULL
along	NULL
with	NULL
either	NULL
mutant	NULL
(	NULL
A207-368	NULL
)	NULL
or	NULL
wild-type	NULL
pGALA-EBNA3C	NULL
are	NULL
compared	NULL
.	NULL

Symbols	NULL
:	NULL
D	NULL
,	NULL
pGAL4-EBNA3Caa11-992	NULL
;	NULL
©	NULL
,	NULL
pGAL4-EBNA3CA207-368	NULL
.	NULL

voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
B	NULL
Fold	NULL
repression	NULL
ug	NULL
EFFECTOR	NULL
activating	NULL
complex	NULL
which	NULL
includes	NULL
CBFI/RBP-Jx	NULL
on	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

The	NULL
failure	NULL
to	NULL
repress	NULL
the	NULL
mutant	NULL
promoter	NULL
described	NULL
above	NULL
must	NULL
therefore	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
EBNA3C	NULL
not	NULL
being	NULL
efficiently	NULL
targeted	NULL
to	NULL
Cp	NULL
DNA	NULL
.	NULL

Further	NULL
evidence	NULL
for	NULL
a	NULL
model	NULL
in	NULL
which	NULL
EBNA3C	NULL
represses	NULL
transcription	NULL
by	NULL
specifically	NULL
associating	NULL
with	NULL
Cp	NULL
comes	NULL
indirectly	NULL
from	NULL
an	NULL
experiment	NULL
in	NULL
which	NULL
the	NULL
deletion	NULL
of	NULL
aa	NULL
207	NULL
to	NULL
368	NULL
was	NULL
functionally	NULL
replaced	NULL
by	NULL
a	NULL
GALA	NULL
DBD	NULL
.	NULL

Cotransfection	NULL
of	NULL
pGALA4-EBNA3Caal1-992A207-368	NULL
with	NULL
pUAS-CAT	NULL
showed	NULL
that	NULL
this	NULL
fusion	NULL
polypeptide	NULL
represses	NULL
almost	NULL
as	NULL
well	NULL
as	NULL
a	NULL
wild-type	NULL
GALA-EBNA3C	NULL
fusion	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
aa	NULL
207	NULL
to	NULL
368	NULL
are	NULL
necessary	NULL
to	NULL
direct	NULL
EBNA3C	NULL
to	NULL
DNA	NULL
and	NULL
are	NULL
therefore	NULL
consistent	NULL
with	NULL
CBF1/RBP-Jx	NULL
playing	NULL
a	NULL
central	NULL
role	NULL
in	NULL
targeting	NULL
EBNA3C	NULL
to	NULL
Cp	NULL
.	NULL

Repression	NULL
of	NULL
Cp	NULL
requires	NULL
the	NULL
domain	NULL
located	NULL
between	NULL
aa	NULL
346	NULL
to	NULL
543	NULL
which	NULL
is	NULL
also	NULL
required	NULL
for	NULL
repression	NULL
by	NULL
EBNA3C-GAL4	NULL
DBD	NULL
fusions	NULL
.	NULL

When	NULL
GAL4-EBNA3C	NULL
was	NULL
targeted	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
promoters	NULL
which	NULL
were	NULL
engineered	NULL
to	NULL
include	NULL
five	NULL
binding	NULL
sites	NULL
for	NULL
GALA	NULL
,	NULL
it	NULL
repressed	NULL
reporter	NULL
gene	NULL
activity	NULL
15-to	NULL
40-fold	NULL
(	NULL
see	NULL
above	NULL
and	NULL
reference	NULL
4	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
GAL4	NULL
fusions	NULL
containing	NULL
smaller	NULL
fragments	NULL
of	NULL
EBNA3C	NULL
revealed	NULL
two	NULL
independent	NULL
regions	NULL
which	NULL
contribute	NULL
to	NULL
repressor	NULL
activity	NULL
.	NULL

The	NULL
more	NULL
potent	NULL
of	NULL
these	NULL
domains	NULL
is	NULL
highly	NULL
acidic	NULL
(	NULL
aa	NULL
280	NULL
to	NULL
525	NULL
)	NULL
,	NULL
and	NULL
when	NULL
linked	NULL
to	NULL
the	NULL
GAL4	NULL
DBD	NULL
,	NULL
it	NULL
repressed	NULL
almost	NULL
as	NULL
well	NULL
as	NULL
the	NULL
near-full-length	NULL
polypeptide	NULL
(	NULL
aa	NULL
11	NULL
to	NULL
992	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

EBV	NULL
EBNA3C	NULL
REPRESSES	NULL
Cp	NULL
BUT	NULL
NOT	NULL
THE	NULL
CD21	NULL
PROMOTER	NULL
-	NULL
8557	NULL
1	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
EBNA3C	NULL
-	NULL
o	NULL
‘	NULL
“	NULL
<	NULL
x	NULL
>	NULL
6	NULL
%	NULL
_..m	NULL
--	NULL
EBNASCA346-543	NULL
#	NULL
mw	NULL
m	NULL
ste	NULL
die	NULL
#	NULL
-	NULL
-	NULL
am	NULL
-o	NULL
CP	NULL
I	NULL
aac	NULL
D	NULL
102	NULL
s	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
EBNA3C	NULL
-	NULL
Sime	NULL
-a-Azo7-368	NULL
-	NULL
_	NULL
``	NULL
``	NULL
C	NULL
ean	NULL
A346-543	NULL
--	NULL
cum	NULL
-	NULL
<	NULL
we	NULL
~	NULL
L______	NULL
L____J	NULL
L_	NULL
U	NULL
L_	NULL
INPUT	NULL
_	NULL
GST-RBP-JK	NULL
:	NULL
500ng	NULL
200ng	NULL
100ng	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

EBNA3C	NULL
requires	NULL
aa	NULL
346	NULL
to	NULL
543	NULL
to	NULL
repress	NULL
Cp	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
p-1425C-CAT	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
pBKCMV-EBNA3CA346-543	NULL
(	NULL
©	NULL
)	NULL
and	NULL
pBKCMV-EBNA3C	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
plotted	NULL
values	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
for	NULL
three	NULL
titration	NULL
experiments	NULL
analyzed	NULL
by	NULL
the	NULL
liquid	NULL
scintillation	NULL
method	NULL
after	NULL
normalization	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
EBNA3C	NULL
expression	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
into	NULL
DG75	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
lysate	NULL
from	NULL
untransfected	NULL
DG75	NULL
cells	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
,	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
mg	NULL
of	NULL
pCMV-EBNA3C	NULL
,	NULL
respectively	NULL
;	NULL
lanes	NULL
7	NULL
to	NULL
11	NULL
,	NULL
lysates	NULL
from	NULL
cells	NULL
similarly	NULL
transfected	NULL
with	NULL
pCMV-EBNA3CA346-543	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunofluorescence	NULL
staining	NULL
of	NULL
C33	NULL
cells	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pCMV-EBNA3CA346-543	NULL
,	NULL
illustrating	NULL
the	NULL
nuclear	NULL
distribution	NULL
of	NULL
the	NULL
mutant	NULL
protein	NULL
.	NULL

(	NULL
D	NULL
)	NULL
GST	NULL
pull-down	NULL
experiment	NULL
showing	NULL
that	NULL
EBNA3CA346-543	NULL
retains	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
GST-RBP-Ix	NULL
fusion	NULL
protein	NULL
.	NULL

Approximately	NULL
equal	NULL
amounts	NULL
of	NULL
5S-labelled	NULL
EBNA3C	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
EBNA3CA346-543	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
,	NULL
and	NULL
EBNA3CA207-368	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
were	NULL
incubated	NULL
separately	NULL
with	NULL
the	NULL
amounts	NULL
of	NULL
GST-CBFI/RBP-Jx	NULL
indicated	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
labelled	NULL
protein	NULL
included	NULL
in	NULL
each	NULL
binding	NULL
reaction	NULL
is	NULL
shown	NULL
below	NULL
lanes	NULL
4	NULL
to	NULL
12	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
significantly	NULL
reduced	NULL
the	NULL
degree	NULL
of	NULL
repression	NULL
but	NULL
did	NULL
not	NULL
abolish	NULL
it	NULL
completely	NULL
.	NULL

To	NULL
analyze	NULL
further	NULL
the	NULL
contribution	NULL
of	NULL
this	NULL
highly	NULL
acidic	NULL
region	NULL
of	NULL
EBNA3C	NULL
to	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
,	NULL
cotransfections	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
plasmid	NULL
pBKCMV-EBNA3CA346-543	NULL
in	NULL
which	NULL
this	NULL
major	NULL
repression	NULL
domain	NULL
had	NULL
largely	NULL
been	NULL
deleted	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Whereas	NULL
in	NULL
parallel	NULL
transfections	NULL
pCMV-driven	NULL
wild-type	NULL
EBNA3C	NULL
repressed	NULL
Cp	NULL
activity	NULL
~10-fold	NULL
,	NULL
the	NULL
deletion	NULL
mutant	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
reporter	NULL
gene	NULL
activity	NULL
driven	NULL
by	NULL
Cp	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
extracts	NULL
made	NULL
from	NULL
cells	NULL
after	NULL
transfection	NULL
showed	NULL
that	NULL
both	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
for	NULL
example	NULL
)	NULL
.	NULL

The	NULL
region	NULL
of	NULL
EBNA3C	NULL
which	NULL
includes	NULL
aa	NULL
346	NULL
to	NULL
543	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
major	NULL
requirement	NULL
for	NULL
repression	NULL
of	NULL
Cp	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
it	NULL
including	NULL
an	NULL
important	NULL
repression	NULL
domain	NULL
.	NULL

The	NULL
deleted	NULL
region	NULL
of	NULL
the	NULL
protein	NULL
also	NULL
includes	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
KKPRKLP	NULL
which	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
potential	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
28	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
amino	NULL
acids	NULL
are	NULL
not	NULL
essential	NULL
to	NULL
target	NULL
EBNA3C	NULL
to	NULL
the	NULL
nucleus	NULL
since	NULL
immunofluorescence	NULL
staining	NULL
of	NULL
cells	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
pBKCMV-EBNA3CA346-543	NULL
showed	NULL
EBNA3C	NULL
distributed	NULL
in	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Previous	NULL
reports	NULL
suggest	NULL
that	NULL
EBNA3CA346-543	NULL
should	NULL
still	NULL
bind	NULL
to	NULL
CBF1/RBP	NULL
-J	NULL
(	NULL
35	NULL
,	NULL
53	NULL
)	NULL
,	NULL
which	NULL
was	NULL
confirmed	NULL
by	NULL
GST	NULL
pull-down	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
found	NULL
that	NULL
at	NULL
high	NULL
concentrations	NULL
of	NULL
GST-RBP-Jx	NULL
fusion	NULL
protein	NULL
there	NULL
was	NULL
significant	NULL
nonspecific	NULL
bind	NULL
8558	NULL
RADKOV	NULL
ET	NULL
AL	NULL
.	NULL

ing	NULL
to	NULL
various	NULL
in	NULL
vitro-translated	NULL
polypeptides	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
a	NULL
titration	NULL
was	NULL
performed	NULL
and	NULL
within	NULL
the	NULL
limitations	NULL
of	NULL
this	NULL
assay	NULL
,	NULL
it	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
A346-543	NULL
binds	NULL
to	NULL
RBP-J	NULL
as	NULL
efficiently	NULL
as	NULL
wild-type	NULL
EBNA3C	NULL
.	NULL

In	NULL
contrast	NULL
and	NULL
as	NULL
predicted	NULL
,	NULL
the	NULL
A207-368	NULL
mutant	NULL
(	NULL
53	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
characterized	NULL
CBF1/RBP-Jx	NULL
binding	NULL
site	NULL
,	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
at	NULL
the	NULL
same	NULL
concentrations	NULL
of	NULL
fusion	NULL
protein	NULL
.	NULL

None	NULL
of	NULL
the	NULL
in	NULL
vitro-translated	NULL
polypeptides	NULL
bound	NULL
to	NULL
wild-type	NULL
GST	NULL
or	NULL
a	NULL
GST	NULL
fusion	NULL
containing	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
TATA-binding	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
reference	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
repression	NULL
of	NULL
Cp	NULL
is	NULL
dependent	NULL
on	NULL
more	NULL
than	NULL
the	NULL
simple	NULL
recruitment	NULL
of	NULL
EBNA3C	NULL
by	NULL
CBFI/RBP-Jk	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
aa	NULL
346	NULL
to	NULL
543	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
EBNA3C	NULL
and	NULL
anOther	NULL
cofactor	NULL
in	NULL
transcriptional	NULL
repression	NULL
.	NULL

Repression	NULL
by	NULL
EBNA3C	NULL
tethered	NULL
to	NULL
DNA	NULL
can	NULL
be	NULL
cell	NULL
type	NULL
specific	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
it	NULL
might	NULL
require	NULL
a	NULL
corepressor	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
GAL4-EBNA3C	NULL
represses	NULL
transcription	NULL
by	NULL
recruiting	NULL
CBFI/RBP-Jk	NULL
to	NULL
DNA	NULL
(	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
above	NULL
and	NULL
elsewhere	NULL
(	NULL
4	NULL
)	NULL
indicate	NULL
that	NULL
this	NULL
is	NULL
unlikely	NULL
and	NULL
that	NULL
in	NULL
these	NULL
fusions	NULL
,	NULL
GALA-DBD	NULL
fulfils	NULL
the	NULL
role	NULL
of	NULL
CBFI/RBP-Jx	NULL
in	NULL
specifically	NULL
localizing	NULL
EBNA3C	NULL
to	NULL
DNA	NULL
.	NULL

We	NULL
and	NULL
others	NULL
previously	NULL
showed	NULL
that	NULL
repression	NULL
by	NULL
GAL4-EBNA3C	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
human	NULL
B	NULL
cells	NULL
but	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
human	NULL
osteosarcoma	NULL
cells	NULL
,	NULL
murine	NULL
fibroblasts	NULL
,	NULL
and	NULL
human	NULL
carcinoma	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
two	NULL
cell	NULL
lines	NULL
have	NULL
subsequently	NULL
been	NULL
identified	NULL
in	NULL
which	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
including	NULL
five	NULL
copies	NULL
of	NULL
UAS	NULL
(	NULL
pUAS-CAT	NULL
)	NULL
functions	NULL
but	NULL
is	NULL
not	NULL
repressed	NULL
by	NULL
GAL4-EBNA3C	NULL
.	NULL

SAOS-2	NULL
is	NULL
a	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
osteosarcoma	NULL
which	NULL
supports	NULL
measurable	NULL
basal	NULL
activity	NULL
from	NULL
pUAS-CAT	NULL
.	NULL

Cotransfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
GALA-EBNA3C	NULL
(	NULL
up	NULL
to	NULL
20	NULL
ug	NULL
)	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Similar	NULL
cotransfections	NULL
using	NULL
the	NULL
cervical	NULL
cancer-derived	NULL
cell	NULL
line	NULL
C33A	NULL
also	NULL
showed	NULL
no	NULL
repression	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
fusion	NULL
protein	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
was	NULL
judged	NULL
by	NULL
Western	NULL
blotting	NULL
to	NULL
be	NULL
equivalent	NULL
to	NULL
that	NULL
in	NULL
transfected	NULL
DG75	NULL
cells	NULL
,	NULL
and	NULL
nuclear	NULL
localization	NULL
was	NULL
demonstrated	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
SAOS-2	NULL
and	NULL
C33A	NULL
cells	NULL
might	NULL
lack	NULL
a	NULL
corepressor	NULL
which	NULL
interacts	NULL
with	NULL
GALA-EBNA3C	NULL
.	NULL

Alternatively	NULL
,	NULL
repression	NULL
by	NULL
EBNA3C	NULL
may	NULL
depend	NULL
on	NULL
posttranslational	NULL
mod-ification	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
,	NULL
which	NULL
may	NULL
differ	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Lack	NULL
of	NULL
repression	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
CBF1/	NULL
RBP-J	NULL
,	NULL
since	NULL
it	NULL
is	NULL
abundantly	NULL
expressed	NULL
in	NULL
both	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
.	NULL

Unfortunately	NULL
,	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
Cp	NULL
(	NULL
p-1425C-CAT	NULL
)	NULL
in	NULL
SAOS-2	NULL
and	NULL
C33A	NULL
cells	NULL
was	NULL
too	NULL
low	NULL
for	NULL
repression	NULL
of	NULL
this	NULL
promoter	NULL
to	NULL
be	NULL
measured	NULL
,	NULL
so	NULL
a	NULL
direct	NULL
assessment	NULL
of	NULL
Cp	NULL
repression	NULL
could	NULL
not	NULL
be	NULL
determined	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

EBNA3C	NULL
has	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
both	NULL
EBNAZ	NULL
and	NULL
EBNA3C	NULL
stimulate	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
CD21	NULL
antigen	NULL
on	NULL
the	NULL
surfaces	NULL
of	NULL
some	NULL
Burkitt	NULL
's	NULL
Iymphoma-derived	NULL
B	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
50	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
the	NULL
EBNA3C-mediated	NULL
activation	NULL
of	NULL
CD21	NULL
may	NULL
occur	NULL
as	NULL
a	NULL
result	NULL
of	NULL
EBNA3C	NULL
binding	NULL
to	NULL
CBF1/RBP-Jk	NULL
and	NULL
inhibiting	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Since	NULL
CBF1/RBP-Jx	NULL
can	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
when	NULL
bound	NULL
to	NULL
DNA	NULL
(	NULL
13	NULL
,	NULL
55	NULL
)	NULL
,	NULL
displacement	NULL
of	NULL
CBF1/RBP-Jk	NULL
from	NULL
its	NULL
cognate	NULL
site	NULL
by	NULL
EBNA3C	NULL
would	NULL
result	NULL
in	NULL
derepression	NULL
,	NULL
that	NULL
is	NULL
,	NULL
activation	NULL
of	NULL
promoters	NULL
bearing	NULL
CBF1/RBP-Jx	NULL
binding	NULL
sites	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
CD21	NULL
promoter	NULL
DNA	NULL
sequence	NULL
reveals	NULL
two	NULL
potential	NULL
CBFI/RBP-Jk	NULL
binding	NULL
sites	NULL
(	NULL
6	NULL
of	NULL
7	NULL
matches	NULL
of	NULL
the	NULL
core	NULL
5'-GTGGGAA-3	NULL
'	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
whether	NULL
CBFI/RBP-Jk	NULL
binds	NULL
to	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
EBNAZ	NULL
and	NULL
EBNA3C	NULL
on	NULL
reporter	NULL
constructs	NULL
including	NULL
up	NULL
to	NULL
1235	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
CD21	NULL
transcriptional	NULL
initiation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

A	NULL
shorter	NULL
promoter	NULL
(	NULL
-467	NULL
CD21-CAT	NULL
)	NULL
was	NULL
included	NULL
in	NULL
the	NULL
study	NULL
because	NULL
it	NULL
J.	NULL
Viror	NULL
.	NULL

A	NULL
)	NULL
``	NULL
7	NULL
I	NULL
jug	NULL
pGAL4	NULL
aat-147	NULL
5	NULL
|	NULL
8	NULL
a	NULL
``	NULL
~O	NULL
``	NULL
~*	NULL
-	NULL
ug	NULL
pGAL4-EBNA3C	NULL
aa1	NULL
1-992	NULL
&	NULL
a	NULL
;	NULL
u	NULL
c	NULL
a	NULL
mc	NULL
el	NULL
u	NULL
w	NULL
2	NULL
E	NULL
®	NULL
w	NULL
ha	NULL
ug	NULL
EFFECTOR	NULL
Z	NULL
o	NULL
0	NULL
#	NULL
w	NULL
C	NULL
a.	NULL
W	NULL
C	NULL
a	NULL
o	NULL
el	NULL
u	NULL
w	NULL
2	NULL
i-5	NULL
w	NULL
C	NULL
ug	NULL
EFFECTOR	NULL
c	NULL
'	NULL
2	NULL
8	NULL
4	NULL
506	NULL
66	NULL
p	NULL
~J-	NULL
cBri/rBP-x	NULL
46	NULL
-	NULL
mss	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
cell	NULL
lines	NULL
which	NULL
do	NULL
not	NULL
support	NULL
the	NULL
transcriptional	NULL
repression	NULL
mediated	NULL
by	NULL
GAL4-EBNA3Caa11-992	NULL
.	NULL

SAOS-2	NULL
or	NULL
C33A	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pUAS-CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
pGAL4-EBNA3Caa11-992	NULL
.	NULL

Titration	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
parallel	NULL
with	NULL
transfections	NULL
using	NULL
pGAL4aa1-147	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Normalized	NULL
CAT	NULL
activities	NULL
were	NULL
expressed	NULL
as	NULL
fold	NULL
repression	NULL
relative	NULL
to	NULL
the	NULL
background	NULL
level	NULL
,	NULL
which	NULL
was	NULL
arbitrarily	NULL
set	NULL
at	NULL
1	NULL
.	NULL

The	NULL
plotted	NULL
values	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
for	NULL
three	NULL
separate	NULL
experiments	NULL
in	NULL
SAOS-2	NULL
(	NULL
A	NULL
)	NULL
and	NULL
C33A	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
CBF1/RBP-Jx	NULL
status	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Approximately	NULL
10°	NULL
cells	NULL
of	NULL
each	NULL
type	NULL
were	NULL
resuspended	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
sonicated	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
clarified	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
transfer	NULL
to	NULL
nitrocellulose	NULL
,	NULL
the	NULL
filter	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
which	NULL
recognizes	NULL
human	NULL
CBF1/RBP-Jx	NULL
(	NULL
isoform	NULL
I	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
CBFI/RBP-Jx	NULL
as	NULL
a	NULL
polypeptide	NULL
of	NULL
approximately	NULL
60	NULL
kDa	NULL
is	NULL
indicated	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
slightly	NULL
faster	NULL
migrating	NULL
species	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
CBF1/RBP-Jx	NULL
,	NULL
which	NULL
was	NULL
used	NULL
as	NULL
a	NULL
marker	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
DG75	NULL
cells	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
NIH	NULL
3T3	NULL
cells	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
U2OS	NULL
cells	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
C33-A	NULL
cells	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
SAOS-2	NULL
cells	NULL
.	NULL

includes	NULL
the	NULL
potential	NULL
CBFI/RBP-Jx	NULL
binding	NULL
sites	NULL
,	NULL
but	NULL
lacking	NULL
an	NULL
upstream	NULL
negative	NULL
element	NULL
,	NULL
it	NULL
has	NULL
a	NULL
moderately	NULL
high	NULL
basal	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
12a	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Cotransfections	NULL
of	NULL
p-1235CD21-CAT	NULL
into	NULL
DG75	NULL
cells	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
pSV-EBNA2Z	NULL
induced	NULL
CAT	NULL
activity	NULL
from	NULL
the	NULL
basal	NULL
level	NULL
as	NULL
much	NULL
as	NULL
27-fold	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
;	NULL
this	NULL
suggests	NULL
there	NULL
might	NULL
be	NULL
legitimate	NULL
CBF1/RBP-Jk	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

A	NULL
similar	NULL
titration	NULL
performed	NULL
with	NULL
p-467CD21-CAT	NULL
produced	NULL
~17-fold	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
when	NULL
these	NULL
CD21	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
~1235	NULL
EBV	NULL
EBNA3C	NULL
REPRESSES	NULL
Cp	NULL
BUT	NULL
NOT	NULL
THE	NULL
CD21	NULL
PROMOTER	NULL
-	NULL
8559	NULL
CAT	NULL
+75	NULL
~467	NULL
+75	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

CD21	NULL
promoter	NULL
constructs	NULL
.	NULL

A	NULL
full-length	NULL
CD21	NULL
promoter	NULL
construct	NULL
(	NULL
p-1235CD21-CAT	NULL
)	NULL
(	NULL
top	NULL
)	NULL
and	NULL
a	NULL
467-bp	NULL
truncation	NULL
(	NULL
p-467CD21-CAT	NULL
)	NULL
(	NULL
31	NULL
)	NULL
(	NULL
bottom	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
TATA	NULL
box	NULL
(	NULL
§	NULL
)	NULL
,	NULL
an	NULL
AP1-like	NULL
squence	NULL
(	NULL
0	NULL
)	NULL
,	NULL
an	NULL
Sp1	NULL
site	NULL
(	NULL
|	NULL
)	NULL
,	NULL
and	NULL
sequences	NULL
which	NULL
are	NULL
identical	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
CD23	NULL
promoter	NULL
(	NULL
RBB	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Two	NULL
potential	NULL
CBFI/RBP-Jx	NULL
binding	NULL
sites	NULL
(	NULL
six	NULL
of	NULL
seven	NULL
matches	NULL
of	NULL
the	NULL
core	NULL
consensus	NULL
sequence	NULL
5	NULL
``	NULL
-GTGGGAA-3	NULL
'	NULL
)	NULL
(	NULL
(	NULL
)	NULL
(	NULL
}	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

Numbers	NULL
are	NULL
the	NULL
nucleotide	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
)	NULL
.	NULL

promoter	NULL
constructs	NULL
were	NULL
each	NULL
cotransfected	NULL
with	NULL
pBKCMV-EBNA3C	NULL
,	NULL
there	NULL
was	NULL
neither	NULL
an	NULL
increase	NULL
nor	NULL
decrease	NULL
in	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

In	NULL
all	NULL
the	NULL
experiments	NULL
with	NULL
the	NULL
CD21	NULL
promoter	NULL
,	NULL
the	NULL
basal	NULL
activity	NULL
was	NULL
low	NULL
enough	NULL
for	NULL
transactivation	NULL
to	NULL
be	NULL
easily	NULL
detected	NULL
(	NULL
for	NULL
example	NULL
,	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
A	NULL
30	NULL
25	NULL
-	NULL
B	NULL
corn	NULL
cat	NULL
T	NULL
E	NULL
20	NULL
-	NULL
A	NULL
467	NULL
c021	NULL
cat	NULL
R	NULL
e	NULL
6	NULL
157	NULL
W	NULL
2	NULL
§	NULL
-	NULL
10	NULL
{	NULL
W	NULL
C	NULL
§	NULL
o	NULL
J	NULL
0	NULL
1	NULL
2	NULL
5	NULL
10	NULL
20	NULL
ug	NULL
pSV-EBNA2	NULL
B	NULL
2	NULL
1.75	NULL
E	NULL
:	NULL
1.57	NULL
3	NULL
G	NULL
<	NULL
<	NULL
o	NULL
w	NULL
2	NULL
3	NULL
W	NULL
&	NULL
C	NULL
ug	NULL
pCMV-EBNA3C	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Effect	NULL
of	NULL
EBNAZ	NULL
and	NULL
EBNA3C	NULL
on	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
p-1235CD21-CAT	NULL
or	NULL
p-467CD21-CAT	NULL
and	NULL
the	NULL
amounts	NULL
of	NULL
pSV-EBNAZ	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DG75	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
p-1235CD21-CAT	NULL
or	NULL
p-467CD21-CAT	NULL
and	NULL
the	NULL
amounts	NULL
of	NULL
pBKCMV-EBNA3C	NULL
indicated	NULL
.	NULL

Multiple	NULL
experiments	NULL
showed	NULL
that	NULL
EBNAZ	NULL
activates	NULL
but	NULL
EBNA3C	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
p-1235CD21-CAT	NULL
or	NULL
p-467CD21-CAT	NULL
:	NULL
in	NULL
each	NULL
case	NULL
,	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
values	NULL
are	NULL
shown	NULL
for	NULL
the	NULL
results	NULL
,	NULL
after	NULL
normalization	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
of	NULL
three	NULL
independent	NULL
titration	NULL
experiments	NULL
analyzed	NULL
by	NULL
the	NULL
liquid	NULL
scintillation	NULL
method	NULL
.	NULL

longer	NULL
promoter	NULL
construction	NULL
(	NULL
p-1235CD21-CAT	NULL
)	NULL
was	NULL
so	NULL
low	NULL
that	NULL
TLC	NULL
assays	NULL
would	NULL
not	NULL
reveal	NULL
repression	NULL
,	NULL
but	NULL
even	NULL
at	NULL
this	NULL
low	NULL
level	NULL
of	NULL
activity	NULL
,	NULL
the	NULL
more-sensitive	NULL
liquid	NULL
scintillation	NULL
assays	NULL
(	NULL
43	NULL
)	NULL
would	NULL
have	NULL
revealed	NULL
severalfold	NULL
repression	NULL
if	NULL
it	NULL
oc-curred	NULL
.	NULL

The	NULL
basal	NULL
activity	NULL
from	NULL
p-467	NULL
was	NULL
sufficiently	NULL
high	NULL
to	NULL
register	NULL
up	NULL
to	NULL
10-fold	NULL
repression	NULL
in	NULL
either	NULL
assay	NULL
system	NULL
,	NULL
but	NULL
no	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
this	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
the	NULL
level	NULL
of	NULL
EBNA3C	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
was	NULL
equivalent	NULL
to	NULL
that	NULL
in	NULL
similar	NULL
experiments	NULL
in	NULL
which	NULL
Cp	NULL
was	NULL
repressed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
EBNA3C	NULL
specifically	NULL
represses	NULL
Cp	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
EBNA3C	NULL
represses	NULL
expression	NULL
from	NULL
reporter	NULL
plasmids	NULL
which	NULL
include	NULL
the	NULL
major	NULL
promoter	NULL
for	NULL
EBNA	NULL
expression	NULL
,	NULL
Cp	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
EBNA3C	NULL
can	NULL
specifically	NULL
regulate	NULL
an	NULL
EBV	NULL
promoter	NULL
independently	NULL
of	NULL
EBNAZ	NULL
activation	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
this	NULL
is	NULL
specific	NULL
to	NULL
Cp	NULL
.	NULL

The	NULL
demonstration	NULL
in	NULL
earlier	NULL
reports	NULL
that	NULL
GAL4-EBNA3C	NULL
repressed	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
,	NULL
mouse	NULL
B-myb	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
only	NULL
when	NULL
GAL4	NULL
binding	NULL
sites	NULL
were	NULL
present	NULL
in	NULL
the	NULL
reporter	NULL
,	NULL
showed	NULL
that	NULL
GALA4-EBNA3C	NULL
(	NULL
11-992	NULL
)	NULL
does	NULL
not	NULL
repress	NULL
by	NULL
nonspecific	NULL
cytotoxicity	NULL
,	NULL
squelching	NULL
,	NULL
or	NULL
posttranslational	NULL
phenomena	NULL
(	NULL
4	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
several	NULL
CD21	NULL
promoter-CAT	NULL
plasmids	NULL
,	NULL
the	NULL
E2RE-Cp	NULL
mutant	NULL
and	NULL
also	NULL
the	NULL
pSV-B-gal	NULL
control	NULL
vector	NULL
were	NULL
all	NULL
unaffected	NULL
by	NULL
full-length	NULL
EBNA3C	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Expression	NULL
from	NULL
other	NULL
EBV-derived	NULL
promoters	NULL
such	NULL
as	NULL
BZLF1	NULL
(	NULL
-221	NULL
)	NULL
and	NULL
LMP1	NULL
(	NULL
-512	NULL
)	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
when	NULL
they	NULL
were	NULL
cotransfected	NULL
with	NULL
EBNA3C	NULL
expression	NULL
vectors	NULL
(	NULL
24	NULL
,	NULL
34	NULL
;	NULL
also	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
the	NULL
human	NULL
B-myb	NULL
promoter	NULL
is	NULL
weakly	NULL
transactivated	NULL
by	NULL
EBNA3C	NULL
(	NULL
27	NULL
)	NULL
.	NULL

All	NULL
these	NULL
data	NULL
testify	NULL
to	NULL
the	NULL
specificity	NULL
of	NULL
EBNA3C-mediated	NULL
repression	NULL
to	NULL
Cp	NULL
.	NULL

Repression	NULL
requires	NULL
CBFI/RBP-Jx	NULL
as	NULL
a	NULL
bridge	NULL
to	NULL
promoter	NULL
DNA	NULL
and	NULL
probably	NULL
involves	NULL
another	NULL
cofactor	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
EBNA3C	NULL
and	NULL
CBF1/	NULL
RBP-J	NULL
can	NULL
interact	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
EBNA3C	NULL
can	NULL
abolish	NULL
EBNAZ-mediated	NULL
transactivation	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
EBNAZ-CBFI/RBP-Jx	NULL
complex	NULL
to	NULL
its	NULL
cognate	NULL
binding	NULL
site	NULL
on	NULL
DNA	NULL
(	NULL
24	NULL
,	NULL
34	NULL
,	NULL
49	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Deletion	NULL
and	NULL
mutation	NULL
analyses	NULL
of	NULL
EBNA3C	NULL
have	NULL
shown	NULL
that	NULL
amino	NULL
acids	NULL
between	NULL
positions	NULL
183	NULL
to	NULL
240	NULL
are	NULL
both	NULL
essential	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
binding	NULL
to	NULL
CBFI/RBP-Jk	NULL
and	NULL
inhibition	NULL
of	NULL
EBNAZ	NULL
transactivation	NULL
;	NULL
substitution	NULL
of	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
with	NULL
alanine	NULL
residues	NULL
abolishes	NULL
the	NULL
interaction	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Our	NULL
current	NULL
data	NULL
convincingly	NULL
show	NULL
that	NULL
both	NULL
the	NULL
CBF1/	NULL
RBP-Jk	NULL
binding	NULL
site	NULL
in	NULL
EBNA3C	NULL
(	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
)	NULL
and	NULL
the	NULL
8560	NULL
RADKOV	NULL
ET	NULL
AL	NULL
.	NULL

interaction	NULL
between	NULL
CBFI/RBP-Jx	NULL
and	NULL
the	NULL
E2RE	NULL
in	NULL
Cp	NULL
are	NULL
required	NULL
but	NULL
are	NULL
not	NULL
sufficient	NULL
for	NULL
EBNA3C	NULL
repression	NULL
of	NULL
Cp	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
targeting	NULL
EBNA3C	NULL
to	NULL
the	NULL
E2RE	NULL
in	NULL
Cp	NULL
.	NULL

This	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
data	NULL
showing	NULL
that	NULL
EBNA3C	NULL
can	NULL
also	NULL
repress	NULL
transcription	NULL
if	NULL
it	NULL
is	NULL
tethered	NULL
to	NULL
various	NULL
promoters	NULL
through	NULL
a	NULL
GAL4-DBD	NULL
(	NULL
4	NULL
,	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
alternative	NULL
interpretation	NULL
of	NULL
this	NULL
repression	NULL
phenomenon	NULL
must	NULL
be	NULL
considered	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
EBNA3C	NULL
can	NULL
disrupt	NULL
CBFI/RBP-Jk	NULL
complexes	NULL
with	NULL
DNA	NULL
,	NULL
so	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
in	NULL
vivo	NULL
EBNA3C	NULL
destabilizes	NULL
the	NULL
interaction	NULL
of	NULL
CBFI/RBP-Jx	NULL
with	NULL
the	NULL
EZRE	NULL
in	NULL
Cp	NULL
.	NULL

In	NULL
order	NULL
to	NULL
cause	NULL
repression	NULL
by	NULL
this	NULL
mechanism	NULL
,	NULL
CBF1/	NULL
RBP-J	NULL
would	NULL
have	NULL
to	NULL
be	NULL
functioning	NULL
as	NULL
an	NULL
activator	NULL
of	NULL
Cp	NULL
in	NULL
DG75	NULL
cells	NULL
.	NULL

Although	NULL
mammalian	NULL
activation	NULL
pathways	NULL
like	NULL
Notch	NULL
exist	NULL
and	NULL
could	NULL
be	NULL
active	NULL
in	NULL
DG75	NULL
cells	NULL
,	NULL
for	NULL
a	NULL
number	NULL
of	NULL
reasons	NULL
we	NULL
think	NULL
this	NULL
is	NULL
an	NULL
unlikely	NULL
explanation	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
seen	NULL
here	NULL
.	NULL

First	NULL
,	NULL
a	NULL
mutant	NULL
of	NULL
EBNA3C	NULL
(	NULL
A346-543	NULL
)	NULL
,	NULL
which	NULL
retains	NULL
the	NULL
RBP-Jk	NULL
binding	NULL
site	NULL
at	NULL
aa	NULL
209	NULL
to	NULL
212	NULL
and	NULL
binds	NULL
to	NULL
CBFI/RBP-Jx	NULL
in	NULL
vitro	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
wild-type	NULL
protein	NULL
,	NULL
does	NULL
not	NULL
repress	NULL
Cp	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
more	NULL
than	NULL
just	NULL
the	NULL
interaction	NULL
with	NULL
RBP-Jk	NULL
is	NULL
required	NULL
.	NULL

Second	NULL
,	NULL
if	NULL
CBF1/	NULL
RBP-J	NULL
were	NULL
activating	NULL
Cp	NULL
in	NULL
DG75	NULL
,	NULL
then	NULL
the	NULL
mutant	NULL
p-1425C-CAT	NULL
E2RE	NULL
promoter	NULL
would	NULL
have	NULL
significantly	NULL
lower	NULL
activity	NULL
in	NULL
DG75	NULL
cells	NULL
than	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

This	NULL
is	NULL
not	NULL
the	NULL
case	NULL
however	NULL
;	NULL
a	NULL
careful	NULL
comparison	NULL
showed	NULL
that	NULL
there	NULL
is	NULL
very	NULL
little	NULL
difference	NULL
between	NULL
the	NULL
basal	NULL
activities	NULL
of	NULL
the	NULL
two	NULL
promoters	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

If	NULL
anything	NULL
,	NULL
the	NULL
mutant	NULL
is	NULL
slightly	NULL
more	NULL
active	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
other	NULL
reports	NULL
of	NULL
comparisons	NULL
between	NULL
reporter	NULL
plasmids	NULL
including	NULL
wild-type	NULL
CBF1/	NULL
RBP-J	NULL
binding	NULL
sites	NULL
and	NULL
their	NULL
mutant	NULL
counterparts	NULL
in	NULL
various	NULL
cells	NULL
,	NULL
including	NULL
DG75	NULL
(	NULL
7	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
while	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
EBNA3C	NULL
physically	NULL
interacts	NULL
with	NULL
CBF1/RBP-Jx	NULL
in	NULL
vivo	NULL
,	NULL
they	NULL
are	NULL
not	NULL
entirely	NULL
consistent	NULL
with	NULL
previous	NULL
models	NULL
which	NULL
proposed	NULL
that	NULL
EBNA3C	NULL
repression	NULL
(	NULL
of	NULL
EBNAZ	NULL
trans-activation	NULL
)	NULL
is	NULL
due	NULL
to	NULL
EBNA3C	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
CBF1/	NULL
RBP-Jk	NULL
to	NULL
DNA	NULL
rather	NULL
than	NULL
forming	NULL
a	NULL
complex	NULL
with	NULL
it	NULL
.	NULL

Such	NULL
models	NULL
were	NULL
based	NULL
largely	NULL
on	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
introduction	NULL
of	NULL
EBNA3C	NULL
into	NULL
electromobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
disrupted	NULL
CBF1/RBP-Jk	NULL
complexes	NULL
with	NULL
DNA	NULL
.	NULL

We	NULL
think	NULL
the	NULL
most	NULL
likely	NULL
explanation	NULL
for	NULL
the	NULL
discrepancy	NULL
between	NULL
these	NULL
data	NULL
and	NULL
our	NULL
current	NULL
model	NULL
is	NULL
that	NULL
EMSAs	NULL
do	NULL
not	NULL
always	NULL
accurately	NULL
reflect	NULL
in	NULL
vivo	NULL
interactions	NULL
.	NULL

This	NULL
is	NULL
certainly	NULL
the	NULL
case	NULL
for	NULL
EBNAZ	NULL
,	NULL
since	NULL
although	NULL
it	NULL
is	NULL
widely	NULL
accepted	NULL
that	NULL
CBF1/	NULL
RBP-Jx	NULL
recruits	NULL
EBNAZ	NULL
to	NULL
DNA	NULL
in	NULL
vivo	NULL
,	NULL
under	NULL
some	NULL
conditions	NULL
EBNAZ	NULL
disrupts	NULL
the	NULL
binding	NULL
of	NULL
CBFI/RBP-Jx	NULL
to	NULL
DNA	NULL
in	NULL
EMSAs	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Because	NULL
aa	NULL
346	NULL
to	NULL
543	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
repression	NULL
of	NULL
Cp	NULL
and	NULL
encompass	NULL
the	NULL
region	NULL
which	NULL
,	NULL
when	NULL
linked	NULL
to	NULL
the	NULL
GAL4	NULL
DBD	NULL
,	NULL
represses	NULL
almost	NULL
as	NULL
well	NULL
as	NULL
wild-type	NULL
EBNA3C	NULL
(	NULL
4	NULL
)	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
it	NULL
makes	NULL
contact	NULL
with	NULL
a	NULL
cellular	NULL
protein	NULL
which	NULL
mediates	NULL
repression	NULL
.	NULL

Since	NULL
such	NULL
a	NULL
molecule	NULL
may	NULL
be	NULL
absent	NULL
or	NULL
unavailable	NULL
for	NULL
binding	NULL
in	NULL
C33	NULL
and	NULL
SAOS-2	NULL
cells	NULL
,	NULL
this	NULL
corepressor	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
transcription	NULL
machinery	NULL
.	NULL

It	NULL
is	NULL
also	NULL
unlikely	NULL
to	NULL
be	NULL
CBFI/RBP-Jx	NULL
,	NULL
since	NULL
this	NULL
is	NULL
abundantly	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
EBNA3C	NULL
can	NULL
bind	NULL
to	NULL
pRb	NULL
in	NULL
vitro	NULL
(	NULL
27	NULL
)	NULL
and	NULL
both	NULL
C33A	NULL
and	NULL
SAOS-2	NULL
cells	NULL
lack	NULL
a	NULL
functional	NULL
pRb	NULL
(	NULL
39	NULL
)	NULL
,	NULL
so	NULL
it	NULL
is	NULL
very	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
pRb	NULL
might	NULL
be	NULL
such	NULL
a	NULL
corepressor	NULL
.	NULL

It	NULL
may	NULL
also	NULL
be	NULL
significant	NULL
that	NULL
GALA4-EBNA3C	NULL
represses	NULL
in	NULL
H1299	NULL
and	NULL
U2O0S	NULL
cells	NULL
which	NULL
,	NULL
like	NULL
C33A	NULL
and	NULL
SAOS-2	NULL
,	NULL
are	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
carcinoma	NULL
and	NULL
an	NULL
osteosarcoma	NULL
,	NULL
re-spectively	NULL
,	NULL
but	NULL
both	NULL
have	NULL
a	NULL
normal	NULL
pRb	NULL
(	NULL
4	NULL
,	NULL
23	NULL
,	NULL
40	NULL
;	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
Rb	NULL
protein	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
when	NULL
targeted	NULL
to	NULL
DNA	NULL
(	NULL
5	NULL
,	NULL
52	NULL
)	NULL
,	NULL
but	NULL
our	NULL
attempts	NULL
to	NULL
rescue	NULL
EBNA3C-mediated	NULL
repression	NULL
in	NULL
C33A	NULL
cells	NULL
by	NULL
titrat-ing	NULL
in	NULL
pCMVpRb	NULL
have	NULL
been	NULL
unsuccessful	NULL
(	NULL
our	NULL
unpublished	NULL
J.	NULL
Viror	NULL
.	NULL

data	NULL
)	NULL
.	NULL

It	NULL
therefore	NULL
seems	NULL
unlikely	NULL
that	NULL
pRb	NULL
is	NULL
involved	NULL
directly	NULL
.	NULL

However	NULL
,	NULL
we	NULL
need	NULL
to	NULL
understand	NULL
how	NULL
pRb	NULL
and	NULL
its	NULL
associated	NULL
cyclin-dependent	NULL
kinases	NULL
are	NULL
regulated	NULL
(	NULL
or	NULL
deregulated	NULL
)	NULL
in	NULL
these	NULL
various	NULL
tumor-derived	NULL
cell	NULL
lines	NULL
before	NULL
we	NULL
can	NULL
fully	NULL
assess	NULL
the	NULL
significance	NULL
of	NULL
these	NULL
results	NULL
.	NULL

EBNA3C	NULL
has	NULL
no	NULL
direct	NULL
effect	NULL
on	NULL
the	NULL
CD21	NULL
promoter	NULL
.	NULL

When	NULL
EBNA3C	NULL
was	NULL
stably	NULL
expressed	NULL
in	NULL
the	NULL
EBV-negative	NULL
lymphoma	NULL
line	NULL
BJAB	NULL
,	NULL
there	NULL
was	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
the	NULL
CD21	NULL
antigen	NULL
on	NULL
the	NULL
cells	NULL
'	NULL
surface	NULL
;	NULL
this	NULL
led	NULL
to	NULL
the	NULL
speculation	NULL
that	NULL
EBNA3C	NULL
may	NULL
regulate	NULL
the	NULL
CD21	NULL
gene	NULL
(	NULL
50	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
by	NULL
cotransfecting	NULL
plasmids	NULL
containing	NULL
the	NULL
CD21	NULL
promoter	NULL
(	NULL
31	NULL
)	NULL
with	NULL
EBNA3C	NULL
expression	NULL
vectors	NULL
.	NULL

Although	NULL
the	NULL
CD21	NULL
promoter	NULL
(	NULL
nucleotide	NULL
-1235	NULL
)	NULL
and	NULL
the	NULL
truncated	NULL
version	NULL
(	NULL
-467	NULL
)	NULL
are	NULL
both	NULL
responsive	NULL
to	NULL
EBNAZ	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
see	NULL
any	NULL
effect	NULL
produced	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
EBNA3C	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
in	NULL
which	NULL
it	NULL
represses	NULL
Cp	NULL
.	NULL

This	NULL
result	NULL
was	NULL
rather	NULL
unexpected	NULL
,	NULL
since	NULL
the	NULL
stable-transfection	NULL
experiments	NULL
had	NULL
suggested	NULL
that	NULL
the	NULL
CD21	NULL
promoter	NULL
might	NULL
be	NULL
activated	NULL
by	NULL
EBNA3C	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Clearly	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
for	NULL
the	NULL
CD21	NULL
promoter-reporter	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

The	NULL
p-1235-CAT	NULL
plasmid	NULL
was	NULL
originally	NULL
defined	NULL
as	NULL
including	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
CD21	NULL
transcriptional	NULL
initiation	NULL
site	NULL
which	NULL
conferred	NULL
B-cell-specific	NULL
activity	NULL
to	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

It	NULL
was	NULL
also	NULL
found	NULL
to	NULL
be	NULL
structurally	NULL
similar	NULL
to	NULL
CD23	NULL
,	NULL
another	NULL
cellular	NULL
promoter	NULL
which	NULL
is	NULL
regulated	NULL
by	NULL
EBV	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
EBNA3C	NULL
does	NULL
not	NULL
directly	NULL
activate	NULL
CD21	NULL
.	NULL

However	NULL
,	NULL
at	NULL
this	NULL
stage	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
EBNA3C-responsive	NULL
element	NULL
not	NULL
included	NULL
in	NULL
p-1235-CAT	NULL
;	NULL
such	NULL
an	NULL
element	NULL
could	NULL
be	NULL
located	NULL
further	NULL
upstream	NULL
than	NULL
nucleotide	NULL
-1235	NULL
or	NULL
possibly	NULL
in	NULL
a	NULL
CD21	NULL
intron	NULL
.	NULL

Although	NULL
the	NULL
original	NULL
prediction	NULL
was	NULL
that	NULL
EBNA3C	NULL
might	NULL
transactivate	NULL
the	NULL
CD21	NULL
promoter	NULL
,	NULL
in	NULL
the	NULL
light	NULL
of	NULL
the	NULL
results	NULL
with	NULL
Cp	NULL
,	NULL
we	NULL
should	NULL
consider	NULL
why	NULL
EBNA3C	NULL
does	NULL
not	NULL
repress	NULL
the	NULL
CD21	NULL
reporters	NULL
in	NULL
DG75	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
two	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
CBF1I/RBP-Jx	NULL
located	NULL
in	NULL
both	NULL
p-1235CD21-CAT	NULL
and	NULL
p-467CD21-CAT	NULL
,	NULL
and	NULL
both	NULL
of	NULL
these	NULL
reporters	NULL
are	NULL
efficiently	NULL
transactivated	NULL
by	NULL
EBNAZ	NULL
.	NULL

If	NULL
EBNAZ	NULL
were	NULL
acting	NULL
through	NULL
these	NULL
sites	NULL
,	NULL
then	NULL
EBNA3C	NULL
might	NULL
be	NULL
expected	NULL
to	NULL
repress	NULL
the	NULL
CD21	NULL
reporters	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
to	NULL
that	NULL
of	NULL
Cp	NULL
.	NULL

Since	NULL
it	NULL
does	NULL
not	NULL
,	NULL
at	NULL
least	NULL
two	NULL
explanations	NULL
should	NULL
be	NULL
considered	NULL
.	NULL

First	NULL
,	NULL
the	NULL
potential	NULL
E2REs	NULL
may	NULL
not	NULL
be	NULL
legitimate	NULL
CBF1/	NULL
RBP-J	NULL
binding	NULL
sites	NULL
and	NULL
EBNAZ	NULL
may	NULL
transactivate	NULL
this	NULL
promoter	NULL
by	NULL
alternative	NULL
mechanisms	NULL
,	NULL
as	NULL
is	NULL
largely	NULL
the	NULL
case	NULL
for	NULL
LMP1	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

A	NULL
second	NULL
,	NULL
more	NULL
intriguing	NULL
possibility	NULL
,	NULL
is	NULL
that	NULL
EBNAZ	NULL
does	NULL
in	NULL
fact	NULL
act	NULL
through	NULL
these	NULL
sites	NULL
and	NULL
that	NULL
EBNA3C	NULL
can	NULL
discriminate	NULL
between	NULL
the	NULL
sites	NULL
in	NULL
the	NULL
CD21	NULL
promoter	NULL
and	NULL
those	NULL
in	NULL
Cp	NULL
.	NULL

It	NULL
will	NULL
not	NULL
be	NULL
possible	NULL
to	NULL
distinguish	NULL
between	NULL
these	NULL
scenarios	NULL
until	NULL
much	NULL
more	NULL
is	NULL
known	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
CD21	NULL
by	NULL
EBV	NULL
.	NULL

These	NULL
experiments	NULL
are	NULL
in	NULL
progress	NULL
but	NULL
are	NULL
beyond	NULL
the	NULL
scope	NULL
of	NULL
this	NULL
investigation	NULL
.	NULL

How	NULL
does	NULL
EBNA3C	NULL
repress	NULL
gene	NULL
expression	NULL
and	NULL
what	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
its	NULL
significance	NULL
in	NULL
the	NULL
life	NULL
cycle	NULL
of	NULL
EBV	NULL
?	NULL

To	NULL
sum-marize	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
EBNA3C	NULL
specifically	NULL
represses	NULL
Cp	NULL
,	NULL
even	NULL
when	NULL
Cp	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
EBNAZ	NULL
and	NULL
the	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
EBNA3C	NULL
being	NULL
targeted	NULL
to	NULL
Cp	NULL
by	NULL
CBFI/RBP-Jx	NULL
.	NULL

The	NULL
precise	NULL
nature	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
EBNAB3C	NULL
and	NULL
Cp	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

It	NULL
is	NULL
still	NULL
unclear	NULL
,	NULL
for	NULL
in-stance	NULL
,	NULL
whether	NULL
additional	NULL
proteins	NULL
are	NULL
involved	NULL
,	NULL
whether	NULL
EBNA3C	NULL
makes	NULL
direct	NULL
contact	NULL
with	NULL
DNA	NULL
,	NULL
or	NULL
whether	NULL
its	NULL
function	NULL
is	NULL
modulated	NULL
by	NULL
posttranslational	NULL
modification	NULL
.	NULL

The	NULL
role	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
the	NULL
potential	NULL
b-ZIP	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Since	NULL
Cp	NULL
is	NULL
the	NULL
site	NULL
of	NULL
initiation	NULL
for	NULL
EBNA	NULL
mRNA	NULL
synthesis	NULL
in	NULL
most	NULL
LCLs	NULL
,	NULL
these	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
EBNA3C	NULL
negatively	NULL
regulating	NULL
its	NULL
own	NULL
expression	NULL
and	NULL
also	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
other	NULL
EBNA	NULL
species	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
therefore	NULL
that	NULL
EBNAB3C	NULL
cooperates	NULL
with	NULL
the	NULL
other	NULL
EBNAs	NULL
in	NULL
a	NULL
complex	NULL
regulatory	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
feedback	NULL
loop	NULL
involving	NULL
frans-activators	NULL
and	NULL
-repressors	NULL
;	NULL
this	NULL
ensures	NULL
tight	NULL
control	NULL
of	NULL
Cp	NULL
activity	NULL
,	NULL
thus	NULL
maintaining	NULL
the	NULL
very	NULL
low	NULL
level	NULL
of	NULL
EBNA-specific	NULL
mRNA	NULL
consistently	NULL
observed	NULL
in	NULL
LCLs	NULL
(	NULL
18	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
there	NULL
may	NULL
be	NULL
some	NULL
specificity	NULL
to	NULL
the	NULL
action	NULL
of	NULL
EBNA3C	NULL
which	NULL
could	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
sequences	NULL
which	NULL
flank	NULL
CBF1I/RBP-Jk	NULL
binding	NULL
sites	NULL
in	NULL
different	NULL
promoters	NULL
.	NULL

Consequently	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
EBNA3C	NULL
also	NULL
affects	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
unidentified	NULL
cell	NULL
genes	NULL
which	NULL
include	NULL
CBFI/RBP-Jx	NULL
binding	NULL
sites	NULL
in	NULL
their	NULL
regulatory	NULL
elements	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
role	NULL
of	NULL
EBNA3C	NULL
in	NULL
growth	NULL
transformation	NULL
by	NULL
EBV	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
addressing	NULL
these	NULL
issues	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
Stoyan	NULL
A.	NULL
Radkov	NULL
and	NULL
Mark	NULL
Bain	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL

This	NULL
research	NULL
was	NULL
partly	NULL
funded	NULL
by	NULL
the	NULL
Royal	NULL
Society	NULL
,	NULL
London	NULL
,	NULL
United	NULL
Kingdom	NULL
,	NULL
which	NULL
provided	NULL
a	NULL
University	NULL
Research	NULL
Fellowship	NULL
to	NULL
M.J.A	NULL
.	NULL

,	NULL
and	NULL
by	NULL
the	NULL
Wellcome	NULL
Trust	NULL
,	NULL
which	NULL
provided	NULL
a	NULL
project	NULL
grant	NULL
to	NULL
MJA	NULL
.	NULL

We	NULL
thank	NULL
Michael	NULL
Holers	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

for	NULL
the	NULL
CD21	NULL
plasmids	NULL
,	NULL
Lars	NULL
Rymo	NULL
(	NULL
Gothenburg	NULL
,	NULL
Sweden	NULL
)	NULL
for	NULL
the	NULL
EBNAZ	NULL
expression	NULL
plasmid	NULL
,	NULL
Diane	NULL
Hayward	NULL
(	NULL
Baltimore	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

for	NULL
the	NULL
GST-CBF1/RBP-Jx	NULL
plasmid	NULL
,	NULL
and	NULL
Erle	NULL
Robertson	NULL
(	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

for	NULL
the	NULL
RBP-J	NULL
antiserum	NULL
.	NULL

We	NULL
are	NULL
also	NULL
very	NULL
grateful	NULL
to	NULL
Gareth	NULL
Inman	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
and	NULL
Gillian	NULL
Parker	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Allday	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Griffin	NULL
.	NULL

1988	NULL
.	NULL

Prediction	NULL
and	NULL
demonstration	NULL
of	NULL
a	NULL
novel	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:4353-4367	NULL
.	NULL

2	NULL
.	NULL

Allday	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Thomas	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
6	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein	NULL
and	NULL
an	NULL
activated	NULL
phenotype	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

74:361-369	NULL
.	NULL

3	NULL
.	NULL

Allday	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1994	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
EBNA3C/6	NULL
expression	NULL
maintains	NULL
the	NULL
level	NULL
of	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
in	NULL
G	NULL
,	NULL
-arrested	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3491-3498	NULL
.	NULL

4	NULL
.	NULL

Bain	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
J.	NULL
Watson	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Allday	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
3C	NULL
is	NULL
a	NULL
powerful	NULL
repressor	NULL
of	NULL
transcription	NULL
when	NULL
tethered	NULL
to	NULL
DNA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2481-2489	NULL
.	NULL

5	NULL
.	NULL

Bremner	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
L.	NULL
Cohen	NULL
,	NULL
M.	NULL
Sopta	NULL
,	NULL
P.	NULL
A.	NULL
Hamel	NULL
,	NULL
C.	NULL
J.	NULL
Ingles	NULL
,	NULL
B.	NULL
L.	NULL
Gallie	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Phillips	NULL
.	NULL

1995	NULL
.	NULL

Direct	NULL
transcriptional	NULL
repression	NULL
by	NULL
pRB	NULL
and	NULL
its	NULL
reversal	NULL
by	NULL
specific	NULL
cyclins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3256-3265	NULL
.	NULL

6	NULL
.	NULL

Cordier	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
M.	NULL
Billaud	NULL
,	NULL
U.	NULL
Zimber	NULL
,	NULL
G.	NULL
Rousselet	NULL
,	NULL
O.	NULL
Pavlish	NULL
,	NULL
J.	NULL
Banchereau	NULL
,	NULL
T.	NULL
Tursz	NULL
,	NULL
G.	NULL
Bornkamm	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Lenoir	NULL
.	NULL

1990	NULL
.	NULL

Stable	NULL
transfection	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
2	NULL
in	NULL
lymphoma	NULL
cells	NULL
containing	NULL
the	NULL
EBV	NULL
P3HR1	NULL
genome	NULL
induces	NULL
expression	NULL
of	NULL
B-cell	NULL
activation	NULL
molecules	NULL
CD21	NULL
and	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1002-1013	NULL
.	NULL

7	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
and	NULL
S.	NULL
Swaminathan	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
genetic	NULL
analysis	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
Cp	NULL
promoter	NULL
function	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1695-1705	NULL
.	NULL

8	NULL
.	NULL

Fahraeus	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Jansson	NULL
,	NULL
A.	NULL
Sfoblom	NULL
,	NULL
T.	NULL
Nilsson	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
L.	NULL
Rymo	NULL
.	NULL

1993	NULL
.	NULL

Cell	NULL
phenotype-dependent	NULL
control	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
gene	NULL
regulatory	NULL
sequences	NULL
.	NULL

Virology	NULL
195:71-80	NULL
.	NULL

9	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

10	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
van	NULL
der	NULL
Eb	NULL
.	NULL

1973	NULL
.	NULL

A	NULL
new	NULL
technique	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
infectivity	NULL
of	NULL
human	NULL
adenovirus	NULL
5	NULL
DNA	NULL
.	NULL

Virology	NULL
52:456-467	NULL
.	NULL

11	NULL
.	NULL

Grossman	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
E.	NULL
Johannsen	NULL
,	NULL
X.	NULL
Tong	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
transactivator	NULL
is	NULL
directed	NULL
to	NULL
response	NULL
elements	NULL
by	NULL
the	NULL
J	NULL
kappa	NULL
recombination	NULL
signal	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:7568-7572	NULL
.	NULL

12	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
D.	NULL
Ling	NULL
,	NULL
S.	NULL
D.	NULL
Hayward	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Peterson	NULL
.	NULL

1994	NULL
.	NULL

Mediation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
EBNA2Z	NULL
transactivation	NULL
by	NULL
recombination	NULL
signal-bind-ing	NULL
protein	NULL
J	NULL
kappa	NULL
.	NULL

Science	NULL
265:92-95	NULL
.	NULL

12a.Holers	NULL
,	NULL
V.	NULL
M.	NULL
Personal	NULL
communication	NULL
.	NULL

13	NULL
.	NULL

Hsieh	NULL
,	NULL
J.	NULL
J.-D.	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
P.	NULL
Salmon	NULL
,	NULL
E.	NULL
Robey	NULL
,	NULL
M.	NULL
G.	NULL
Peterson	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1996	NULL
.	NULL

Truncated	NULL
mammalian	NULL
Notch	NULL
]	NULL
activates	NULL
pressed	NULL
genes	NULL
by	NULL
a	NULL
mechanism	NULL
resembling	NULL
that	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
EBNAZ	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:952-959	NULL
.	NULL

14	NULL
.	NULL

Joab	NULL
,	NULL
L	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
M.	NULL
Bodescot	NULL
,	NULL
J.	NULL
C.	NULL
Nicolas	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
and	NULL
M.	NULL
Perricaudet	NULL
.	NULL

1987	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
gene	NULL
coding	NULL
for	NULL
Epstein-Barr	NULL
virus-de-termined	NULL
nuclear	NULL
antigen	NULL
EBNA3	NULL
and	NULL
its	NULL
transient	NULL
overexpression	NULL
in	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
by	NULL
using	NULL
an	NULL
adenovirus	NULL
expression	NULL
vector	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3340-3344	NULL
.	NULL

15	NULL
.	NULL

Johannsen	NULL
,	NULL
E.	NULL
,	NULL
E.	NULL
Kob	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
X.	NULL
Tong	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
S.	NULL
R.	NULL
Grossman	NULL
.	NULL

1995	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
transactivation	NULL
of	NULL
the	NULL
latent	NULL
mem-	NULL
EBV	NULL
EBNA3C	NULL
REPRESSES	NULL
Cp	NULL
BUT	NULL
NOT	NULL
THE	NULL
CD21	NULL
PROMOTER	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

8561	NULL
brane	NULL
protein	NULL
1	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
Jx	NULL
and	NULL
PU.1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:253-262	NULL
.	NULL

Johannsen	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
L.	NULL
Miller	NULL
,	NULL
S.	NULL
R.	NULL
Grossman	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1996	NULL
.	NULL

EBNA-2	NULL
and	NULL
EBNA-3C	NULL
extensively	NULL
and	NULL
mutually	NULL
exclusively	NULL
associate	NULL
with	NULL
RBPJx	NULL
in	NULL
Epstein-Barr	NULL
virus-transformed	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:4179-4183	NULL
.	NULL

Kallin	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Dillner	NULL
,	NULL
I.	NULL
Ernberg	NULL
,	NULL
B.	NULL
Ehlin-Henriksson	NULL
,	NULL
A.	NULL
Rosen	NULL
,	NULL
W.	NULL
Henle	NULL
,	NULL
G.	NULL
Henle	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1986	NULL
.	NULL

Four	NULL
virally	NULL
determined	NULL
nuclear	NULL
antigens	NULL
are	NULL
expressed	NULL
in	NULL
Epstein-Barr	NULL
virus-transformed	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:1499-1503	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
,	NULL
p.	NULL
2343-2396	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Virology	NULL
.	NULL

Lippincott-Raven	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
J.	NULL
Sheen	NULL
.	NULL

1995	NULL
.	NULL

Isotopic	NULL
assays	NULL
for	NULL
reporter	NULL
gene	NULL
activity	NULL
,	NULL
p.	NULL
9.7.1-9.7.11	NULL
.	NULL

In	NULL
F.	NULL
M.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y	NULL
.	NULL

Le	NULL
Roux	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Kerdiles	NULL
,	NULL
D.	NULL
Walls	NULL
,	NULL
J.	NULL
F.	NULL
Dedieu	NULL
,	NULL
and	NULL
M.	NULL
Perricaudet	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
determined	NULL
nuclear	NULL
antigens	NULL
EBNA-3A	NULL
,	NULL
-3B	NULL
,	NULL
and	NULL
-3C	NULL
repress	NULL
EBNA-2-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
viral	NULL
terminal	NULL
protein	NULL
1	NULL
gene	NULL
promoter	NULL
.	NULL

Virology	NULL
205:596-602	NULL
.	NULL

Ling	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
J.	NULL
J.	NULL
Hsieh	NULL
,	NULL
I.	NULL
K.	NULL
Ruf	NULL
,	NULL
D.	NULL
R.	NULL
Rawlins	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1994	NULL
.	NULL

EBNA-2	NULL
upregulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
promoters	NULL
and	NULL
the	NULL
cellular	NULL
CD23	NULL
promoter	NULL
utilizes	NULL
a	NULL
common	NULL
targeting	NULL
intermediate	NULL
,	NULL
CBF1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:5375-5383	NULL
.	NULL

Ling	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
D.	NULL
R.	NULL
Rawlins	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
immortalizing	NULL
protein	NULL
EBNA-2	NULL
is	NULL
targeted	NULL
to	NULL
DNA	NULL
by	NULL
a	NULL
cellular	NULL
enhancer-binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9237-9241	NULL
.	NULL

Lukas	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Parry	NULL
,	NULL
L.	NULL
Aagaard	NULL
,	NULL
D.	NULL
J.	NULL
Mann	NULL
,	NULL
J.	NULL
Bartkova	NULL
,	NULL
M.	NULL
Strauss	NULL
,	NULL
G.	NULL
Peters	NULL
,	NULL
and	NULL
J.	NULL
Bartek	NULL
.	NULL

1995	NULL
.	NULL

Retinoblastoma-protein-dependent	NULL
cell-cycle	NULL
inhibition	NULL
by	NULL
the	NULL
tumour	NULL
suppressor	NULL
p16	NULL
.	NULL

Nature	NULL
375:503-506	NULL
.	NULL

Marshall	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
C.	NULL
Sample	NULL
.	NULL

1995	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
3C	NULL
is	NULL
a	NULL
transcriptional	NULL
regulator	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3624-3630.	NULL
.	NULL

Maunders	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
Petti	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1994	NULL
.	NULL

Precipitation	NULL
of	NULL
the	NULL
Epstein	NULL
Barr	NULL
virus	NULL
protein	NULL
EBNA	NULL
2	NULL
by	NULL
an	NULL
EBNA	NULL
3c-specific	NULL
monoclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

75:769-778	NULL
.	NULL

Meitinger	NULL
,	NULL
C.	NULL
,	NULL
L.	NULL
J.	NULL
Strobl	NULL
,	NULL
G.	NULL
Marschall	NULL
,	NULL
G.	NULL
W.	NULL
Borokamm	NULL
,	NULL
and	NULL
U.	NULL
Zimber-Strobl	NULL
.	NULL

1994	NULL
.	NULL

Crucial	NULL
sequences	NULL
within	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
TP1	NULL
promoter	NULL
for	NULL
EBNAZ-mediated	NULL
transactivation	NULL
and	NULL
interaction	NULL
of	NULL
EBNAZ	NULL
with	NULL
its	NULL
responsive	NULL
element	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:7497-7506	NULL
.	NULL

Parker	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
T.	NULL
Crook	NULL
,	NULL
M.	NULL
Bain	NULL
,	NULL
E.	NULL
A.	NULL
Sara	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Allday	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
(	NULL
EBNA	NULL
)	NULL
3C	NULL
is	NULL
an	NULL
immortalizing	NULL
oncoprotein	NULL
with	NULL
similar	NULL
properties	NULL
to	NULL
adenovirus	NULL
E1A	NULL
and	NULL
papillomavirus	NULL
E7	NULL
.	NULL

Oncogene	NULL
13:2541-2549	NULL
.	NULL

Petti	NULL
,	NULL
L.	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
fifth	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
(	NULL
EBNA3C	NULL
)	NULL
is	NULL
expressed	NULL
in	NULL
latently	NULL
infected	NULL
growth-trans-formed	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:1330-1338	NULL
.	NULL

Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
IE2	NULL
gene	NULL
products	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
specifically	NULL
down-regulate	NULL
expression	NULL
from	NULL
the	NULL
major	NULL
imme-diate-carly	NULL
promoter	NULL
through	NULL
a	NULL
target	NULL
sequence	NULL
located	NULL
near	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:6154-6165	NULL
.	NULL

Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
P.	NULL
O'Hare	NULL
,	NULL
L.	NULL
Sha	NULL
,	NULL
R.	NULL
L.	NULL
LaFemina	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1988.	NULL
trans-Activation	NULL
and	NULL
autoregulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
imme-diate-carly	NULL
region	NULL
2	NULL
gene	NULL
products	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62	NULL
:	NULL
1167-1179	NULL
.	NULL

Rayhel	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
M.	NULL
H.	NULL
Dehoff	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Holers	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
complement	NULL
receptor	NULL
2	NULL
(	NULL
CR2	NULL
,	NULL
CD21	NULL
)	NULL
promoter	NULL
reveals	NULL
sequences	NULL
shared	NULL
with	NULL
regulatory	NULL
regions	NULL
of	NULL
other	NULL
developmentally	NULL
restricted	NULL
B	NULL
cell	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:2021-2026	NULL
.	NULL

Rickinson	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
,	NULL
p.	NULL
2397-2446	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Virology	NULL
.	NULL

Lippincott-Raven	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
Ricksten	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Kallin	NULL
,	NULL
H.	NULL
Alexander	NULL
,	NULL
J.	NULL
Dillner	NULL
,	NULL
R.	NULL
Fahraeus	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
R.	NULL
Lerner	NULL
,	NULL
and	NULL
L.	NULL
Rymo	NULL
.	NULL

1988	NULL
.	NULL

BamHI	NULL
E	NULL
region	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
encodes	NULL
three	NULL
transformation-associated	NULL
nuclear	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:995-999	NULL
.	NULL

Robertson	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
S.	NULL
Grossman	NULL
,	NULL
E.	NULL
Johannsen	NULL
,	NULL
C.	NULL
Miller	NULL
,	NULL
J.	NULL
Lin	NULL
,	NULL
B.	NULL
Tomkinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
,	NULL
1995	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
3C	NULL
modulates	NULL
transcription	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
Jx	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3108-3116	NULL
.	NULL

Robertson	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
J.	NULL
Lin	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
amino-terminal	NULL
domains	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
3A	NULL
,	NULL
3B	NULL
,	NULL
and	NULL
3C	NULL
interact	NULL
with	NULL
RBPJk	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:3068-3074	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
M.	NULL
Brimmell	NULL
,	NULL
M.	NULL
Buschle	NULL
,	NULL
G.	NULL
Allan	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Kolman	NULL
.	NULL

1992	NULL
.	NULL

Host	NULL
cell	NULL
and	NULL
EBNA-2	NULL
regulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
la-tent-cycle	NULL
promoter	NULL
activity	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:496-504	NULL
.	NULL

Sample	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
B.	NULL
Parker	NULL
.	NULL

1994	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
3A	NULL
and	NULL
3C	NULL
proteins	NULL
.	NULL

Virology	NULL
205:534-539	NULL
.	NULL

Sample	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Young	NULL
,	NULL
B.	NULL
Martin	NULL
,	NULL
T.	NULL
Chatman	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
differ	NULL
in	NULL
their	NULL
EBNA-3A	NULL
,	NULL
EBNA-3B	NULL
,	NULL
and	NULL
EBNA-3C	NULL
genes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4084-4092	NULL
.	NULL

Scheffner	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Munger	NULL
,	NULL
J.	NULL
C.	NULL
Byrne	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
state	NULL
of	NULL
the	NULL
p53	NULL
and	NULL
retinoblastoma	NULL
genes	NULL
in	NULL
human	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
lines	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5523-5527	NULL
.	NULL

8562	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

RADKOV	NULL
ET	NULL
AL	NULL
.	NULL

Shimizu	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Coxon	NULL
,	NULL
G.	NULL
A.	NULL
Otterson	NULL
,	NULL
S.	NULL
M.	NULL
Steinberg	NULL
,	NULL
R.	NULL
A.	NULL
Kratzke	NULL
,	NULL
Y.	NULL
W.	NULL
Kim	NULL
,	NULL
J.	NULL
Fedorko	NULL
,	NULL
H.	NULL
Oie	NULL
,	NULL
B.	NULL
E.	NULL
Johnson	NULL
,	NULL
J.	NULL
L.	NULL
Mulshine	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
and	NULL
F.	NULL
J.	NULL
Kaye	NULL
.	NULL

1994	NULL
.	NULL

RB	NULL
protein	NULL
status	NULL
and	NULL
clinical	NULL
correlation	NULL
from	NULL
171	NULL
cell	NULL
lines	NULL
representing	NULL
lung	NULL
cancer	NULL
,	NULL
extrapulmonary	NULL
small	NULL
cell	NULL
carcinoma	NULL
,	NULL
and	NULL
mesothelioma	NULL
.	NULL

Oncogene	NULL
9:2441-2448	NULL
.	NULL

Sjoblom	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Jansson	NULL
,	NULL
W.	NULL
Yang	NULL
,	NULL
S.	NULL
Lain	NULL
,	NULL
T.	NULL
Nilsson	NULL
,	NULL
and	NULL
L.	NULL
Rymo	NULL
.	NULL

1995	NULL
.	NULL

PU	NULL
box-binding	NULL
transcription	NULL
factors	NULL
and	NULL
a	NULL
POU	NULL
domain	NULL
protein	NULL
cooperate	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
2-induced	NULL
transactivation	NULL
of	NULL
the	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76:2679-2692	NULL
.	NULL

Sjoblom	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Nerstedt	NULL
,	NULL
A.	NULL
Jansson	NULL
,	NULL
and	NULL
L.	NULL
Rymo	NULL
.	NULL

1995	NULL
.	NULL

Domains	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
(	NULL
EBNAZ	NULL
)	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
and	NULL
the	NULL
EBNA	NULL
Cp	NULL
promoters	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76:2660-2678	NULL
.	NULL

Sleigh	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1986	NULL
.	NULL

Non	NULL
chromatographic	NULL
assay	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
gene	NULL
in	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

156	NULL
:	NULL
251-256	NULL
.	NULL

Thomas	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
J.	NULL
Allday	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Crawford	NULL
.	NULL

1991	NULL
.	NULL

Epstein-Barr	NULL
virus-associated	NULL
lymphoproliferative	NULL
disorders	NULL
in	NULL
immunocompromised	NULL
individu-als	NULL
.	NULL

Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

57:329-380	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1992	NULL
.	NULL

Use	NULL
of	NULL
second-site	NULL
homologous	NULL
recombination	NULL
to	NULL
demonstrate	NULL
that	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
3B	NULL
is	NULL
not	NULL
important	NULL
for	NULL
lymphocyte	NULL
infection	NULL
or	NULL
growth	NULL
transformation	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:2893-2903	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Robertson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
EBNA-3A	NULL
and	NULL
EBNA-3C	NULL
are	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2014-2025	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Y.	NULL
Bourillot	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
E.	NULL
Manet	NULL
.	NULL

1995	NULL
.	NULL

RBP-J	NULL
kappa	NULL
repression	NULL
activity	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
co-repressor	NULL
and	NULL
antagonized	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transcription	NULL
factor	NULL
EBNAZ	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
23:4939-4945	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
C.	NULL
Brou	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
E.	NULL
Manet	NULL
.	NULL

1994	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

S1	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

The	NULL
human	NULL
J	NULL
kappa	NULL
recombination	NULL
signal	NULL
sequence	NULL
binding	NULL
protein	NULL
(	NULL
RBP-J	NULL
kappa	NULL
)	NULL
targets	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
EBNAZ	NULL
protein	NULL
to	NULL
its	NULL
DNA	NULL
responsive	NULL
elements	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5633-5638	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Perricaudet	NULL
,	NULL
A	NULL
.	NULL

Sergeant	NULL
,	NULL
and	NULL
E.	NULL
Manet	NULL
.	NULL

1996	NULL
.	NULL

Epstcin-Barr	NULL
virus	NULL
EBNA3A	NULL
and	NULL
EBNA3C	NULL
proteins	NULL
both	NULL
repress	NULL
RBP-J	NULL
«	NULL
-EBNA2-acti-vated	NULL
transcription	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
RBP-J	NULL
to	NULL
DNA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:5909-5915	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
C.	NULL
Sample	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2309-2318	NULL
.	NULL

Watson	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
C.	NULL
Robinson	NULL
,	NULL
and	NULL
E.	NULL
W.	NULL
Lam	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
regulation	NULL
by	NULL
murine	NULL
B-myb	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
by	NULL
c-myb	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:267-272	NULL
.	NULL

Weintraub	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
K.	NULL
N.	NULL
Chow	NULL
,	NULL
R.	NULL
X.	NULL
Luo	NULL
,	NULL
S.	NULL
H.	NULL
Zhang	NULL
,	NULL
S.	NULL
He	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
active	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Nature	NULL
375:812-815	NULL
.	NULL

Zhao	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
R.	NULL
Marshall	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Sample	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
conserved	NULL
domain	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigens	NULL
3A	NULL
and	NULL
3C	NULL
binds	NULL
to	NULL
a	NULL
discrete	NULL
domain	NULL
of	NULL
Jx	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:4228-4236	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
E.	NULL
Kremmer	NULL
,	NULL
F.	NULL
Grasser	NULL
,	NULL
G.	NULL
Marschall	NULL
,	NULL
G.	NULL
Laux	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Bornkamm	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
interacts	NULL
with	NULL
an	NULL
EBNAZ	NULL
responsive	NULL
cis-clement	NULL
of	NULL
the	NULL
terminal	NULL
protein	NULL
1	NULL
gene	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:167-175	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
L.	NULL
J.	NULL
Strobl	NULL
,	NULL
C.	NULL
Meitinger	NULL
,	NULL
R.	NULL
Hinrichs	NULL
,	NULL
T.	NULL
Sakai	NULL
,	NULL
T.	NULL
Furukawa	NULL
,	NULL
T.	NULL
Honjo	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Borakamm	NULL
.	NULL

1994	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
exerts	NULL
its	NULL
transactivating	NULL
function	NULL
through	NULL
interaction	NULL
with	NULL
recombination	NULL
signal	NULL
binding	NULL
protein	NULL
RBP-J	NULL
kappa	NULL
,	NULL
the	NULL
homologue	NULL
of	NULL
Drosophila	NULL
Suppressor	NULL
of	NULL
Hairless	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4973-4982	NULL
.	NULL

